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ABSTRACT
Heart failure (HF) is a syndrome that primarily affects the aged and is the most
common hospital discharge diagnosis for adults in the United States. Readmission is
common following discharge from an acute hospital stay for HF. Patients with HF suffer
more depressive morbidity than other patients with cardiovascular disease, and many age
65 or older experience social isolation.
This prospective exploratory study examined whether readmission within 30 to 60
days of discharge from an index hospitalization for HF was associated with depressive
symptoms or social isolation. A convenience sample of 101 patients participated during
an index hospitalization for HF. Participants were followed-up for any readmissions
within 30 or 60 days of discharge. Depressive symptoms were measured with the 15-item
Geriatric Depression Scale (GDS-15) and social isolation with the Lubben Social
Network Scale (LSNS).
At least one readmission for HF occurred for 27 participants within 30 days and
for 31 within 60 days. Cronbach‘s alpha for the GDS-15 was extremely low (.39), and
few participants (n = 9) had scores consistent with risk for depression; hence, GDS-15
scores were inadequate for testing any association with readmission. The LSNS was
reliable ( = .77), and 13 participants (13%) had scores consistent with social isolation.
There was no association between social isolation and readmission within 30 or 60 days.
However, responses to the LSNS helped to identify several patients whose need for social
services had not been identified by hospital staff. In exploratory analyses, b-type
natriuretic peptide (BNP) within 24 hours of the index admission was associated with
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readmission, median = 3327 vs. 852 pg/ml, p=.056, and 3782 vs. 845 pg ml, p=.016 for
any vs. no readmission within 30 or 60 days, respectively.
Limitations include convenience sampling and possible sampling bias as well as a
relatively brief follow-up period. Despite the lack of association with readmission, there
may be other reasons for screening patients hospitalized for HF for depression or social
isolation. The association between BNP and readmission merits further investigation in a
study designed for that purpose.
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Chapter 1
Introduction
Heart failure (HF) is the most common adult cause of hospitalization, with more
than a million hospitalizations annually in the U. S. (Rosamond et al., 2007; Writing
Group Members, Lloyd-Jones, Adams, Brown, Carnethon, Dai, S., et al. 2010).
According to the American Heart Association (Writing Group Members et al., 2010),
over 5 million Americans have heart failure, and the direct and indirect costs of HF
exceed $39 billion per year in the U. S. (Writing Group Members et al.). Among this
population, heart failure readmission rates range from 25 to 50% within six months of a
hospitalization (Jerant, Azari, & Nesbitt, 2001). The AHA recommends implementing
strategies to reduce preventable readmissions to reduce their impact on the economic
burden of HF to society. This, in turn, requires greater understanding about factors that
may influence readmissions. The purpose of this investigation is to explore emotional and
social issues that may influence readmission of individuals with HF.
Heart failure is a syndrome that primarily affects the aged. It exists when the heart
muscle is weakened sufficiently to impair its capacity to fill with or pump sufficient
blood to meet the body‘s physiologic demands (Hunt et al., 2005). According to the Heart
Failure Society of America (HFSA) (2006a, 2006b):
HF is a syndrome caused by cardiac dysfunction, generally resulting from
myocardial muscle dysfunction or loss and characterized by left ventricular
dilation or hypertrophy. Whether the dysfunction is primarily systolic or diastolic
or mixed, it leads to neurohormonal and circulatory abnormalities, usually
resulting in characteristic symptoms such as fluid retention, shortness of breath,
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and fatigue, especially on exertion. In the absence of appropriate therapeutic
intervention, HF is usually progressive at the levels of cardiac function and
clinical symptoms. The severity of clinical symptoms may vary substantially
during the course of the disease process and may not correlate with changes in
underlying cardiac function. Although HF is progressive and often fatal, patients
can be stabilized and myocardial dysfunction and remodeling may improve, either
spontaneously or as a consequence of therapy.
In physiologic terms, HF is a syndrome characterized by elevated cardiac
filling pressure or inadequate peripheral oxygen delivery, at rest or during stress,
caused by cardiac dysfunction. (HFSA, 2006b, p. 14).
The causes of heart failure can be classified into four categories 1) work overload
of the ventricle 2) oxygen deprivation of the myocardium such as hypoxia, ischemia,
infarction, and or fibrosis 3) cardiomyopathies and 4) altered cardiac rhythm (Hunt et al.,
2005). Work overload refers to increased preload (e.g., increased venous return as in fluid
overload, or mitral or tricuspid regurgitation) or afterload (e.g., systemic arterial
hypertension, pulmonary arterial hypertension, stenosis of the aortic or pulmonic valves;
Hunt et al.).
Ischemia is a condition of oxygen deprivation and subsequent inadequate removal
of metabolites. The oxygen demand of the heart may be affected by atherosclerotic
disease. Atherosclerosis may result in loss of myocardial contractility, increased wall
stress, and decreased ventricular compliance (Hunt, et al. 2005). Heart failure is a
common sequela of long-term ischemic coronary artery disease, commonly, though not
always, following myocardial infarction (Hunt et al.).
2

Cardiomyopathies are characterized by hypertrophy or hyperplasia of the
myocardium, and are generally classified as dilated, hypertrophic, restrictive,
arrhythmogenic right ventricular, and unclassified (Elliott, et al., 2008; Richardson, et al.,
1996). Although it is common in clinical practice to make inferences about etiology (e.g.,
ischemic vs. nonischemic based on cardiac catheterization), formal classification schemes
focus more on structural and functional characteristics of myocardium, whether or not
etiology is known (Elliott, et al.; Richardson, et al.). Dilated cardiomyopathies are
characterized by ventricular chamber dilation, systolic dysfunction, elevated left
ventricular filling pressure and diminished systolic ejection fraction (Cohn, 2007). These
cardiomyopathies often result from myocardial injury due to alcohol or drug abuse, toxic
exposures, or viral infections. Restrictive cardiomyopathies may be idiopathic or
associated with other diseases (e.g., amyloidosis, scleroderma; Elliott et al.). They are
characterized by the impairment of diastolic filling and relaxation which results in
depressed cardiac output. Hypertrophic cardiomyopathy (HCM) is characterized by
marked hypertrophy of the left ventricle. HCM often has a genetic basis, and is a
common cause of sudden death in young, apparently healthy, athletes (Cohn, 2007).
However, all classifications can have familial / genetic or non-familial / non-genetic
etiologies (Elliott et al.).
Lastly, altered rhythms can be associated with HF or cardiomyopathy, either as an
etiological factor or as a consequence or correlate. For example, atrial fibrillation occurs
frequently in the presence of systemic arteriolar hypertension and mitral valve disease.
Atrial fibrillation results in near-complete loss of effective atrial contraction (sometimes
called ‗atrial kick‘). In the presence of rapid or impaired ventricular response, this may
3

reduce cardiac output substantially (Cohn, 2007). Tachydysrhythmias may shorten
diastolic filling time and result in decreased stroke volume. Rapid heart rate also
increases oxygen demand in patients with atherosclerotic coronary artery disease (CAD),
tachycardias may induce or worsen myocardial ischemia, further depressing myocardial
function (Cohn).
In the U. S., functional capacity of patients with HF is commonly graded
according to the New York Heart Association (NYHA) four-level classification scheme
(NYHA, 1994, as cited in American Heart Association, 2007).
Class I: The patient has no limitation of activities, and ordinary physical
activity does not provoke symptoms of dyspnea, fatigue, palpitations or
angina.
Class II: The patient has slight, mild limitation of activity but is comfortable at
rest; ordinary physical activity provokes symptoms of dyspnea, fatigue,
palpitations or angina.
Class III: The patient has marked limitation of activity, comfortable only at
rest. Less than ordinary physical activity provokes symptoms of dyspnea,
fatigue, palpitations or angina.
Class IV: Inability to perform any physical activity without discomfort and
symptoms may occur at rest.(American Heart Association, 2007)
In keeping with the heterogeneous etiologies and presentations of heart failure symptoms,
the classification is based primarily on symptoms and their impact on activities, but all
categories presume there is objective evidence of cardiovascular disease (American Heart
Association, 2007).
4

It is well documented that co-morbidities such as renal dysfunction, chronic
obstructive pulmonary disease, diabetes, and hypertension increase the risk of
readmission among patients with HF. Indeed, it has been estimated that 40% of patients
with heart failure have five or more noncardiac comorbidities, and that this group
accounts for 81% of total inpatient hospital days (Braunstein et al., 2003). Braunstein and
colleagues also concluded that, following hypertension and diabetes, the noncardiac co
morbidities most frequently experienced by patients included chronic obstructive
pulmonary disease (26%), osteoarthritis (16%), chronic respiratory failure or lower
respiratory failure (14%), thyroid disease (14%), Alzheimer‘s disease or other dementia
(9%), depression (8%), chronic renal failure (7%), asthma (5%), osteoporosis (5%), and
anxiety disorders (3%).
Demographics
In the United States there are approximately 35 million persons over the age of
65, and the most rapid growth in population is occurring in those over the age of 85
(Centers for Disease Control & Merck Company Foundation, 2007). The aging of the
population, due in part to increases in life expectancy, including those due to medical
advances, means that more Americans than in the past survive to an age at which HF is
common (Cohn, 2007). As a person ages the risk of age-dependent heart failure begins to
increase, in particular from abnormalities of ventricular relaxation, aging of the
vasculature structures, and increased prevalence of coronary artery disease (Cohn).
Moreover, as survival from myocardial infarction improved over the last several decades,
due to advances in emergency cardiac care, interventional cardiology, and cardiac
surgery, some of those saved go on to develop HF. Even improvements in the treatment
5

of HF itself have contributed to the rising prevalence of HF, to the extent such treatments
are effective in extending life expectancy.
Social Isolation
With the general increase in life expectancy, there has also been a dramatic
increase in the number of elders living alone. In 1910 only 12% of widowed elders lived
alone; nowadays, approximately 40 percent of elders live alone (Hays & George, 2002).
Demographers attribute the trend to generally lower fertility rates and a growing
preference for privacy. However, there appears to be a significant pattern among elders
who live alone. Many are frail, disabled, and widowed; they are also more likely to be
economically deprived, lonely, and suffer from depression ( Bertera & Bertera, 2008).
Additionally, social isolation has become such a concern that the World Health
Organization (WHO) has recognized the prevention of social isolation as necessary for
good health (WHO, 2002).
Social isolation can be defined in two ways. One reflects the type and frequency
of social contacts. The other reflects the degree to which a person perceives that certain
types of support are available. A person is only socially isolated if he or she defines the
amount of contact with others as inadequate (Aquino, Altmaier, Russell, & Cutrona,
1996). It is important to remember that living alone does not necessarily make someone
isolated; solitude can be a personal choice. For example, social isolation may refer to a
physical separation from other people, such as living alone or living in a rural or isolated
area. But, it may also refer to a person who chooses to be socially isolated, for example
the elder who has chosen to live at some distance from family and friends.
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Also, the number of persons or personal daily contacts may be a factor related to
adequate social support. Social isolation appears to affect persons with fewer than three
people in their social support network (Stuart-Shor, Buselli, Carroll, & Forman, 2003).
Individuals with smaller social support networks report the lack of a confidant, and
attending fewer social functions. When elders over the age of 85 were asked about the
number of friends, 42% reported a decrease in the size of their network. The mean size of
an active social network for an elder has been reported to be from five to seven people
(Stuart-Shor et al.) with older persons consistently reporting fewer people in their social
support groups.
Depression
Heart failure patients suffer significant depressive morbidity; characterized by
identifying symptoms of depression (Turvey, Shcultz, Arndt, Wallace, & Herzog, 2005).
Some symptoms may be attributed to the deterioration in health status (Fitzsimons et al.,
2007). In one qualitative study examining patient needs in chronic illness, one heart
failure patient described his depression in the following manner:
I don‘t feel like going out. I have been feeling depressed…. I just didn‘t want to
get out of bed. I felt the same way as I did when I went into the hospital. I feel
absolutely rotten. I couldn‘t care less about anything. (Fitzsimons et al., 2007,
p.320)
In the same study, the clinical staff identified depression as a problem for the heart failure
population:
Well, perhaps there is something proactive that we could do? Are we under
assessing our patient‘s moods? I know we treat them with our evidence based
7

medicine for their physical condition; maybe there is something else we could do
to help psychologically? (Fitzsimons, 2007, p 320)
Nurses and other providers have recognized that depression is a common problem
in patients with HF (Fitzsimons et al., 2007). Major depression is present in 17% to 37%
of patients with HF, and minor depression is present in 16% to 22% (Koenig, 2006; Lang
& Mancini, 2006). Among heart failure patients, depression is associated with more
frequent hospital readmissions, a decline in activities of daily living, and worse New
York Heart Association (NYHA) functional classification (Vaccarino, Kasl, Abramson,
& Krumholz, 2001; Murberg & Bru, 2001).
Based on the information currently available, it is important for nurses who care
for patients with HF to begin to explore in detail the perspective of the heart failure
patient. It is important to begin to account for chronology of events or experiences of the
heart failure patient, to determine where and when assistance should begin. Without
further exploration the potential for continued high readmission rates for HF will
continue.
This study is intended to further the knowledge related to symptom identification
of patients with heart failure. Managing symptoms of the patient with heart failure is key
to a positive outcome. As patients move through the continuum of acute to palliative care,
the focus of the interventions may change, but the importance of treating depression and
of identifying social isolation remains. This study should increase the awareness that
depressive symptoms and social isolation are common among patients with heart failure
and should add to the growing body of knowledge for the care and support of people
undergoing heart failure treatment.
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Major depression. The standard psychiatric definition of major depressive
disorder (MDD or major depression) as defined by the Diagnostic and Statistical Manual
of Mental Disorders-Fourth edition-Text Revision (DSM-IV-TR; American Psychiatric
Association, 2000) entails axis 1 criteria that require confirmation by a trained therapist.
A diagnosis of MDD implies confirmation that a person has been experiencing at least
five of nine possible symptoms, for at least two weeks and that this is a departure from
the individual’s prior level of functioning. At least one of those symptoms must be a
depressed mood or a loss of interest or pleasure (anhedonia) in all or nearly all activities
most of the time (nearly every day). Depressed mood and anhedonia may be ascertained
by self-report or by report of others (American Psychiatric Association, 2000). Other
symptoms may include:
Considerable loss or gain of weight (5% change in a month, when not
dieting.) There may also be a decrease or increase in appetite.
Difficulty falling asleep or staying asleep (insomnia), or sleeping more than
usual (hypersomnia).
Agitated behavior or slowed down behavior. Others should be able to observe
this behavior change.
Feelings of fatigue or diminished energy.
Thoughts of worthlessness or extreme guilt.
Reduced or impaired ability to think, concentrate, or make decisions.
Frequent thoughts of death or suicide (with or without a specific plan), or an
attempt of suicide. (American Psychiatric Association, 2000)
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These symptoms cause great distress or difficulty in functioning at home, work, or in
personal areas of daily life. According to the DSM- IV-TR criteria, the person‘s
symptoms are not caused by substance abuse, are not due to normal grief or bereavement
over the death of a loved one, or by another diagnosis such as schizophrenia (American
Psychiatric Association, 2000).
Complicating the assessment of depression in patients with HF, many of the
symptoms of depression are common symptoms of heart failure. Hospitalized HF patients
frequently report low energy, fatigue, and difficulty enjoying themselves. In addition,
sleep disturbances and sleep disorders are common among patients with HF (Turvey et
al., 2005). Many patients and providers assume such symptoms are to be expected in
anyone with HF, or as a part of getting old; accordingly, depression in patients with HF
may remain undiagnosed and untreated or under treated.
Minor depression. Minor depression is less disabling than major depression and
may last up to two years. It is defined as having 2 to 4 depressive symptoms, of which at
least one must be depressed mood or anhedonia, in either case, the symptoms should be
occurring most of the day, more often (more days) than not (American Psychiatric
Association, 2000). Minor depression is also referred to as subsyndromal depression,
mild depression, subclinical depression, and subthreshold depression. Minor depression
that has persisted for more than two years (with no episodes of suicidal ideation or
attempts) may be indicative of dysthymic disorder (another axis one mood disorder). In
general, minor depression among the elderly is more common than major depression
(Lyness, King, Cox, Yoediono, & Caine, 1999), but this may not always be the case
among patients with HF (Koenig, 2006; Lang & Mancini, 2006).
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Depression in older adults. Major depressive disorder in older adults can be
divided according to time of onset: early life major depression onset, and late life onset
(after age 65). The early life onset of major depression typically recurs before age 65 and
continues as the person continues to age. Late life depression is depression occurring
after age 65, and it may be associated with biological, psychological and social factors
(Lapid & Rummans, 2000). Late life depression may occur more frequently in the
context of severe or chronic medical illness. Major depression is a serious comorbidity
for heart failure patients, with the more depressed dying sooner (Murberg & Furze,
2004).
Murberg & Furze (2004) conducted a longitudinal study of mortality in
community-residing patients with HF in Norway. The Zung self rating depression scale
(SDS) was utilized to assess for symptoms of depression. In this study 51 out of 119
patients died during a six year follow up period, all from cardiac causes. Patients who
were depressed were two and a half times more likely to die within six years than those
who were not depressed. The increase in relative risk (RR) for each 1-point increase on
the SDS was 1.05 (95% CI, 1.00 to 1.08, p =.016), controlling for sex, age, trait
neuroticism, and natriuretic peptide levels (a surrogate marker for HF severity).
Heart Failure Exacerbation
Heart failure exacerbation is also known as acute decompensated heart failure; it
represents new or worsening signs and symptoms of dyspnea, fatigue or edema that may
lead to hospitalization or an unscheduled medical visit. Acute decompensated heart
failure is a common problem for patients over the age of 65, and it is associated with
major morbidity and mortality (Allen & O‘Connor, 2007). Heart failure exacerbations
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occur for a variety of reasons (Knox & Mischke, 1999), not all of which are
ascertainable. Cardiac causes may include ischemia, pressure or volume overload, or
abnormally high or low cardiac output. Other causes of exacerbations may include poorly
controlled hypertension, inflammation or infection, lack of adherence with medications,
or substance abuse. According to Knox and Mischke, problems in adhering to
medications or dietary restrictions and failures of social support are commonly implicated
in exacerbation. However, I believe that the potential difficulty adhering to HF medical
regimens may also be due to increased difficulty in identifying the symptom origin. A
clearer understanding is needed of the combination of physiological and psychosocial
symptoms that occurs in HF patients, as well as situational and environmental factors that
affect their symptom experience and most importantly the joint effects of combinations of
these factors.
Conceptual Framework
The conceptual framework for this investigation is the theory of unpleasant
symptoms (TOUS), (Lenz, Pugh, Milligan, Gift, & Suppe, 1997; Lenz, Suppe, Gift,
Pugh, & Milligan, 1995). The theory of unpleasant symptoms (TOUS) was developed
initially by nurses who had been conducting research on two different symptoms:
dyspnea and fatigue. In collaborative discussions, they realized that there were many
common elements across these symptoms such that if a nurse understood one symptom,
much of that knowledge might apply to the other, and possibly to any unpleasant
symptom (Gift et al., 2004). The TOUS addresses symptom recognition and symptom
reporting. It is believed that people are able to identify symptoms as a departure from
normal functioning (Lenz et al., 1997, 1995), attach a meaning, and make decisions or
12

take some action (including deciding not to take action). Additionally, the TOUS assumes
that persons or their caregivers are able to communicate or correctly interpret the
symptoms.
According to the TOUS, symptoms are fundamentally unpleasant sensory
perceptual experiences in relation to illness or altered health status that can be
characterized in terms of their intensity, sensory quality, timing (duration and frequency),
and concomitant distress (Lenz et al., 1997, 1995). Symptoms can be further
characterized as being influenced by physiological, psychosocial, and situational or
environmental factors (antecedent or influencing factors) and as having consequences or
impacts on performance, functioning, or quality of life (Lenz et al., 1997, 1995).
The physiological component of the model includes factors such as the involved
organ systems, tissues, and cells, pathological alterations, and metabolic status (e.g.,
nutrition, elimination of waste products). Psychosocial influencing factors or antecedents
could include personality traits, pre-existing depression or other mood disorders, and
reactions to an illness state, such as help-seeking or marshaling of social support.
Situational factors might include type of employment, occupational or environmental
exposures, cultural beliefs, and living situation (e.g., social isolation). Consequences or
impacts on performance relate to physical, cognitive and role functioning and also quality
of life (Lenz et al., 1997, 1995). A refinement of the original model (Lenz et al., 1997)
also took into account that symptoms often occur in combinations or clusters, not in
isolation, and emphasized more explicitly the potential for feedback among the three
levels of the model (influencing factors, symptom experience, and performance or
impact).
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In terms of this dissertation, it should be noted that social isolation is viewed
under the TOUS as primarily an antecedent or influencing factor (whether conceived of
as psychosocial, situational / environmental, or both). In contrast, although depression
can be a pre-existing / influencing factor, it may also be a concomitant symptom (i.e.,
part of a cluster or constellation of concurrent symptoms), or a reaction or consequence
of acute or disabling symptoms (e.g., after a myocardial infarction or an exacerbation of
chronic HF). On the other hand, distress is a somewhat ambiguous term that refers either
to the unpleasantness of sensation or to a person‘s emotions and evaluative judgments
about the possible meaning of what is felt (Armstrong, 2003; Price, 2000; Wells &
Ridner, 2008). Regardless, under the terms of the TOUS, distress is held to be part of the
symptom experience itself, not a separate symptom. When multiple symptoms interact, as
in a symptom cluster, distress may become amplified.
Diseases and syndromes are commonly characterized by groups of symptoms
(clusters) that alert the patient that something is wrong and which commonly serve the
health care professional as a starting point for history taking and diagnostic testing. In the
psychological and psychiatric literature, clinicians have historically used symptom
clustering (multiple symptoms) to diagnose and better understand psychological disorders
(Faustman & Ficek, 2002). Indeed, one of the main rationales for the DSM axis system
was to systematize what combinations of symptoms were necessary for a diagnosis and
which and how many others had to be present for a diagnostic label to apply. In medicine,
symptom clusters are also characteristic of syndromes such as heart failure or chronic
obstructive pulmonary disease that may be heterogeneous in terms of etiology or
phenotype. Symptoms of HF may vary to some degree depending on whether it primarily
14

involves systolic or diastolic dysfunction or right or left ventricular failure. However,
common signs and symptoms of HF include fatigue, dyspnea (especially dyspnea on
exertion, orthopnea, or paroxysmal nocturnal dyspnea), and peripheral or pulmonary
edema.
It wasn‘t until the late 1990‘s that a new approach was sought to assist in the
management of multiple symptoms: how they were expressed and experienced (Dodd,
Miaskowski, & Lee, 2004, Miaskowski, Dodd & Lee, 2004). The belief is that
understanding synergistic relationships and interactions among symptoms can optimize
symptom management. The TOUS assists in explaining what the symptom experience
consists of as well as factors that influence symptoms and outcomes that symptoms
influence. The theory views symptoms as interactive, rather than simply additive.
In summary, experiencing multiple symptoms is an integral aspect of living with
HF. The TOUS helps to examine each symptom as an interactive component. The theory
is based on the assumption that sufficient commonalities exist among symptoms, and
acknowledges potential interactions among multiple symptoms. In heart failure, the
physiological, psychosocial, and situational factors implicated in classic symptoms of
heart failure, such as dyspnea and fatigue, may also be responsible for producing
secondary symptoms (e.g., depression). In addition, medications taken for heart failure
management may also contribute to depressive symptomatology.
In contrast, social isolation is not a symptom per se, but it could influence either
the severity of symptomatology or how effectively or ineffectively the patient copes with
HF symptoms and treatment. Alternatively, in some cases, it could be a response to or
outcome of depression and other symptoms. Patients with depression may begin to
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exhibit behaviors that adversely affect social activities. For example, unmanaged
depression may lead to inactivity, and inactivity may lead to withdrawal from friends and
family.
Specific Aims of the Study
The specific aims of this exploratory study were to determine whether
readmission in elderly patients with heart failure is associated with differences in
depressive symptoms, social isolation, or both. The primary independent variable was
readmission status at 30 and 60 days following discharge from an index hospitalization
for heart failure. For the dependent variables, depressive symptoms were measured with
the Geriatric Depression Scale (15-item version; GDS-15; Sheikh & Yesavage, 1986;
Yesavage et al., 1983), and social isolation was measured with the 18-item version of the
Lubben Social network Scale (LSNS-18; Lubben & Gironda, 2003). Hypotheses for the
study were that patients readmitted within 30 to 60 days of discharge from an index
hospitalization for HF would differ from patients who are not readmitted in terms of
depressive symptoms (GDS-15 scores) and social isolation (LSNS-18 scores) during the
index hospitalization. Other patient characteristics to be assessed in exploratory analyses
included gender, race and ethnicity, age, educational level, ejection fraction (preserved
vs. reduced), NYHA classification level, and b-type natriuretic peptide (BNP) levels
drawn within 24 hours of admission.
Potential Significance
The treatment of heart failure centers on complex medication and dietary
regimens. For adequate symptom management, patients must be motivated and be willing
to learn their treatment regimen, should weigh themselves daily, and should be cognizant
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of any changes in their symptoms or activity tolerance. On any given day, symptoms may
vary in number and in the intensity, duration or frequency, quality, and the amount of
distress associated with them. The symptom and economic burdens of HF may be
substantial; causing patients to become depressed or the heart failure treatment itself may
cause patients to become depressed. Either way, untreated depression potentially affects
the lives of heart failure patients adversely. Furthermore, patients who are depressed may
remove themselves from social activities, or the physiological symptoms of heart failure
may begin to remove heart failure patients from social activities. When social isolation is
experienced, a person may be psychologically challenged by lack of social contacts,
friendships, or motivation in ways that may interfere with recognition of heart failure
symptoms or with self-management (Brummett et al., 2001). This descriptive study,
comparing levels of depression and social isolation between patients with and without a
readmission for heart failure may provide insight into the potential importance of
assessing depressive symptoms and social isolation when patients with HF are
hospitalized. If it turns out there are systematic differences in either depression or social
isolation scores between those who subsequently are versus are not readmitted within 30
to 60 days, it would support the need for a larger, prospective study of the predictive
utility of measures of depressive symptoms or social isolation in this population in the
setting of an acute hospitalization for HF.
Limitations
The limitations of this study include:
1. The study is observational and will necessarily involve a convenience sample
of inpatients willing to participate.
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2. This study includes only participants from one health care system in southeast
Texas therefore, the findings may not be generalizable beyond that locale.
3. Participation is limited to patients who are able to speak and write in English
or Spanish and who are not cognitively impaired.
4. It is assumed that self reported scores for depressive symptoms and social
isolation are accurate, and that those willing to participate in an observational
study are motivated to self-report honestly.
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Chapter 2
Review of the Literature
Symptoms are subjective experiences of illness that are typically described in
terms of alterations in physiological, psychosocial, or behavioral functioning as perceived
by the person experiencing them (Hegyvary, 1993). Typically symptoms are contrasted
with signs, objective manifestations of illness detectable or measurable by others.
However, it is not uncommon for there to be considerable ambiguity between symptoms
and signs, and in some cases the same term may be used to label either a symptom or a
sign. For example, patients may report having edema on the basis of subjective sensations
(e.g., shoes or jewelry not fitting) or on the basis of an increasing trend in daily weights;
both can carry the same label, edema, but the former is edema as symptom, the latter is
edema as a sign. Either could indicate a possible worsening of heart failure. Similarly,
angina pectoris, per se, is a symptom, but when a patient reports its occurrence during a
stress test, it is a sign that further diagnostic and, perhaps, interventional activities are
called for.
Despite important conceptual distinctions between symptoms, signs, and disease,
from the patient‘s perspective, these are often fused at the experiential level such that the
signs (e.g., peripheral edema) and symptoms (e.g., dyspnea and fatigue) are the disease
or, at least, surrogates for it (Hegyvary, 1993). Patients are unlikely to present for care
with complaints about their ejection fraction or oxygen saturation; they are far more
likely to complain that they can no longer walk short distances without becoming
severely anginal, fatigued, or breathless.
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The most basic definitions of symptoms are disturbances of sensation or function
that a person experiences as unpleasant, out of the ordinary, or distressing in relation to a
usual or ideal state of health or functioning. By themselves, however, symptoms are
generally nonspecific with respect to any particular disease or condition (Aronowitz,
2001). Hegyvary (1993) suggested that symptoms potentially are what a person takes to
be ―red flags‖ (p.146) that something is not right and that may prompt help-seeking
activities.
Within the theory of unpleasant symptoms (TOUS; Lenz et al., 1997, 1995),
symptoms are characterized as disturbances in sensation or function that are perceived as
unpleasant by the person experiencing them and that have: (a) physiological,
psychological, and situational (social and physical environment) antecedents; (b)
elements of intensity, sensory quality, distress, and timing (e.g., frequency and duration);
and (c) impacts or consequences for behavior, affect, cognition, physical functioning, and
perceived health status (collectively termed performance in the model). Importantly, the
model posits feedback and interaction among the various levels and among multiple more
or less concurrent symptoms (Lenz et al., 1997). For example, if symptoms lead to
inactivity (a behavioral consequence) deconditioning or depression may ensue, and these,
in turn may worsen the patient‘s underlying physiological and psychosocial condition. On
the other hand, if symptoms lead to appropriate help-seeking and treatment of underlying
etiologies (hypertension, ischemic coronary artery disease), particularly if combined with
structured physical activity as in a rehabilitation program, underlying physiological and
psychosocial functioning may stabilize or even improve to some degree.
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In this chapter heart failure will be examined from the standpoint of the TOUS
(see Figure 1). First, I will provide a brief overview of physiological,
psychosocial/behavioral, and situational factors. Then symptoms will be examined. It
should be understood that the levels and categories within levels of the TOUS do not
represent hard and fast distinctions, let alone imply mutually exclusive categories. For
example, social isolation has both psychological and situational/environmental aspects;
therefore these will be approached jointly below. Depression can have both physiological
and psychological aspects, it can be a pre-existing (antecedent) condition, but it is also a
common symptom among patients with HF, many of whom may not have suffered from
depression previously. Lastly, the impacts and outcomes of HF will be examined in terms
of cognitive, affective, and behavioral consequences or outcomes.
Antecedent Factors
Physiological. Common causes of HF include ischemic coronary artery disease,
hypertension, and cardiomyopathy, or cardiac remodeling often in conjunction with
aging, chronic ischemia, and myocardial injury (e.g., following infarction) (American
Heart Association, 2005; Hunt et al., 2005). Heart Failure often develops slowly over
time and symptoms begin to appear as the heart loses its ability to fill with or pump blood
(Heart Failure Society of America, 2006a. 2006b; Hunt et al.).
Systolic vs. diastolic dysfunction or classification by ejection fraction (EF).
What traditionally used to be referred to as congestive heart failure (CHF) was
categorized clinically as primarily left sided (characterized by diminished left ventricular
function and pulmonary congestion) or right sided (characterized more by peripheral
edema, often in a setting of chronic pulmonary or renal disease). Nowadays, the more
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general term, heart failure, is preferred, and HF is more often characterized as either
systolic versus diastolic dysfunction or, in terms of ejection fraction, as either decreased
or preserved.
Systolic dysfunction implies impaired ability of the ventricle (primarily the L
ventricle) to empty, as manifested by a reduced ventricular ejection fraction. Criteria for
reduced left ventricular ejection fraction (LVEF) are somewhat variable. There is general
agreement that LVEF of 50% or above is preserved. Some classify LVEF less than 50%
as diminished (Owan et al., 2006), whereas others consider an EF between 40 and 50% to
be borderline and reserve the term ‗reduced ejection fraction‘ for those with an LVEF
less than 40% (Bhatia et al., 2006).
Diastolic dysfunction implies an impairment of ventricular filling, typically from
reduced distensibility or impaired ventricular relaxation of the left ventricle, regardless of
whether ejection fraction is preserved or reduced (Aurigemma & Gaasch, 2004).
Diastolic heart failure or heart failure with preserved left ventricular (LV) systolic
function (ejection fraction) is recognized as a major growing epidemiological problem
(Aurigemma & Gaasch, 2004; Bhatia et al., 2006; Owan et al., 2006), with at least one
third to nearly half of HF patients presenting initially with preserved LV systolic function
(Aurigemma & Gasch; Bhatia et al.; Chen, Lainchbury, Senni, Bailey, & Redfield, 2002;
Owan et al.). The diagnosis of diastolic dysfunction is complex and is best made by
Doppler imaging and by assessing the architecture of the heart by echocardiography.
All patients with heart failure and preserved EF can be considered to have
diastolic dysfunction, and all patients with systolic dysfunction have reduced ejection
fraction. However, some patients with reduced ejection fraction can have mixed systolic
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and diastolic dysfunction, although the usual net result is that the former predominates.
Therefore, the primary distinction between classifications by type of dysfunction versus
by ejection fraction is that systolic vs. diastolic dysfunction refers to a presumed
underlying mechanism, whereas classification by ejection fraction is based on the net
consequence as estimated by echocardiography, nuclear scintigraphy, or, in some cases,
during coronary angiography. While classification by ejection fraction is more objective,
all measures of EF require interpretation and depend on the skill and experience of those
performing and reading the test.
Recent community and population based studies (Bhatia et al., 2006; Owan et al.,
2006) suggest that reduced LVEF is more common in men, whereas HF with preserved
EF is more common in women. In these two studies, patients with preserved EF were, on
average, slightly but significantly older than those with reduced EF. The prevalence of
coronary artery disease and ischemia in those two studies was significantly higher in
patients with reduced compared with preserved LVEF, but CAD was still present in one
third to one half of patients with preserved EF (Bhatia et al.; Owan et al.). Systemic
hypertension was significantly more prevalent in patients with preserved compared to
reduced LVEF, but was still present in approximately half of patients with reduced LVEF
(Bhatia et al.; Owan et al.). Atrial fibrillation was, likewise, significantly more prevalent
in patients with preserved LVEF (approximately 30 to 40%) compared with reduced
LVEF (approximately 24 to 28%) (Bhatia et al.; Owan et al.).
Coexisting factors. There are a variety of coexisting factors that may contribute
to heart failure. In recent years, the importance of ventricular remodeling secondary to
increases in circulating catecholamines and chronic over stimulation of the renin23

angiotensin system has been recognized. Increasingly, angiotensin converting enzyme
(ACE) inhibitors and -blockers have become mainstays of HF treatment, especially in
systolic dysfunction (Hunt et al., 2005; HFSA, 2006a). In addition, aging is associated
with numerous molecular, biochemical, cellular, and biomechanical changes in the heart
and the cardiovascular and respiratory systems. For example, cardiac aging results in
changes in vasculature, systemic and pulmonary perfusion, and pulmonary function.
In addition, diabetes is commonly associated with hypertension, increased risk for
ischemic cardiovascular disease, obesity, and chronic kidney disease. End-stage renal
failure is often associated with increased risk for fluid overload. Therefore, the risk for
and severity of heart failure are higher in patients with diabetes or renal failure (or both)
than in the general population of persons without these conditions. Moreover, in the
presence of either or both of these conditions, HF may be more challenging to work up
(e.g., increased risks associated with contrast media administered during coronary
angiography in patients with decreased glomerular filtration or chronic kidney disease)
and more complex to treat (e.g., increased complexity of dietary and medication
regimes).
Vasculature. Aging may affect both large arteries and smaller resistance vessels
(e.g., arterioles). The collagen and elastic elements of the wall matrix may change, and
vessel walls may thicken. As a result, vascular stiffness generally increases with age
(Francis, Tang, & Sonnenblick, 2004).
Current guidelines (Chobanian, et al., 2003) define hypertension at 140 mmHg
systolic and 90 mmHg diastolic; moreover, the risk of adverse cardiovascular events
(e.g., myocardial infarction, stroke) is more strongly related to systolic than diastolic
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hypertension in older adults (> 50 years of age). From a baseline of 115/70 mmHg,
relative risk of cardiovascular disease doubles for each incremental increase of 20 mmHg
systolic or 10 mmHg diastolic (National High Blood Pressure Education Program
[NHBPEP], 2004). Additionally, there have been studies documenting geographic
variations associated with rises in blood pressure and aging. Geographic variations in
blood pressure suggest that blood pressure does not rise as much with age as in non
industrialized societies (Elford, Phillips, Thomson, & Shaper, 1990).
Cardiac adaptation. Arterial stiffening triggers a variety of cardiac adjustments,
for example, chronically elevated left ventricular afterload causes left ventricular wall
thickening from an increase in the size of cardiac myocytes (i.e., as opposed to
hyperplasia, an increase in the number of myocytes; Francis et al., 2004). Also, the
combination of late augmentation of aortic impedance and left ventricular hypertrophy
prolongs myocardial contraction. The prolonged contraction time can contribute to
preserved left ventricular pump function, and thus, to a point, may be compensatory
(Francis et al.).
With aging comes a decline in diastolic filling of up to 50% (Francis et al). While
this may occur because of mechanical reasons (prolonged contraction time), the decrease
in early diastolic filling may be caused by a prolonged relaxation time between aortic
valve closing and the mitral valve opening (Lakatta, 1999).
In aging men, an elevated end diastolic volume may tend to maintain cardiac
output by increasing stroke volume in the presence of an age-related decline in heart rate.
In women, there tends to be little or no increase in end diastolic volume, and so, cardiac
output decreases with increasing age (Lakatta, 1999). For women, menopause is
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associated with an increase in risk of heart disease. However, there is, at best, no
cardiovascular benefit from hormone replacement therapy (HRT) for menopausal women
(Hsia et al., 2006); at worst, HRT actually increases risk of cardiovascular events
(Writing Group for the Women's Health Initiative Investigators, 2002). Therefore, HRT
is not recommended as prophylaxis against cardiovascular disease in menopausal women.
Circulation. Aging is also associated with structural and functional changes in
coronary vasculature. There is an age-related decline in coronary flow reserve which may
be a result of elevated baseline cardiac work and myocardial blood flow (Priebe, 2000).
Additionally, the vasodilator capacity of coronary circulation has been shown to have
higher coronary resistance in older subjects, suggesting that some impairment of
vasodilatation may contribute to impaired vasodilator capacity (Czernin et al, 1993). It is
also believed that as the heart ages, the heart rate reflex response to alterations in arterial
pressure is impaired. This may compromise arterial pressure homeostasis in response to
diuretic therapy, altered fluid intake and postural stress (Priebe, 2000).
One of the major alterations in the aging heart is a decreased ability to respond to
exercise. There is a decrease in heart rate and contractile response with age as evidenced
by decreases in peak heart rate and peak ejection fraction. The age associated decline in
heart rate and LV contractility is due to diminished beta adrenergic modulation of
contractility, and vasomotor tone (Francis et al, 2004). In the elderly, the increased
demand for peripheral blood flow in exercise or exertion is met primarily by activation of
the preload reserve. Thus, increased demand results in reduced cardiovascular reserve
and coronary insufficiency which are important underlying risk factors for acute and
chronic heart failure in the elderly (Francis et al).
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Overall, heart failure is characterized by a downward trend in physical
functioning. Patients with heart failure experience not only functional losses but erratic
patterns of physical functioning. The HF failure patient must learn to appropriately
identify, cope with, and manage symptoms (Redwine et al., 2007).
Categorizing HF. There are several methods to categorize the limitations of
physical activity causing discomfort. One method is the categorical system of the New
York Heart Association (NYHA). The NYHA classification scale was developed in 1928.
Since that time two major revisions have been made (AHA, 2007). The current
recommended use for the NYHA (Bonow, 2005; Hunt, 2005) involves a two part grading
process involving subjective and objective observation. From the subjective perspective,
patients are asked to describe the symptoms they experience during physical activity.
Then data from specific medical examinations such as echocardiograms,
electrocardiograms, or cardiac catheterizations are used to measure cardiac structure and
function. From an objective point of view, clinicians are asked to categorize patients on
four levels: 1) no objective evidence of cardiovascular disease 2) objective evidence of
minimal cardiovascular disease 3) objective evidence of moderately severe
cardiovascular disease and 4) objective evidence of severe cardiovascular disease.
NYHA Class I describes patients with cardiovascular disease but without any
physical limitations. Class II describes a person with slight limitation of physical activity.
Class III describes a person with limited physical activity and Class IV describes a person
unable to carry on any physical activity without becoming incapacitated by symptoms
(e.g., dyspnea, fatigue, chest pain) or myocardial ischemia or infarction.
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Additionally, a newer classification system developed by the American Heart
Association and the American College of Cardiologists (Hunt et al., 2005) attempts to
recognize earlier stages in the disease process. It too, consists of four stages: Stage A
includes patients who are at high risk for HF but do not have structural heart disease or
symptoms of HF. For example this would include patients with hypertension,
atherosclerotic cardiovascular disease, dyslipidemia, diabetes (or risk factors such as
obesity or metabolic syndrome) or patients with cardiomyopathy or a family history
thereof. While these patients might not have signs or symptoms of HF, hypertension and
other risk factors would need to be controlled. Patients should be counseled to avoid
behaviors that may increase the development of HF (smoking, illicit drug use). If cardiac
rhythms are abnormal, they would need to be controlled among this group. Also any
secondary prevention strategy should be employed: monitoring thyroid disorders as well
as atherosclerotic disease.
Stage B includes patients with structural disorders or a functional abnormality of
the pericardium, myocardium, or the cardiac valves who have never shown signs or
symptoms of HF, but whose structural or functional abnormality is commonly associated
with the development of HF. This group should also have all the interventions of stage A,
in addition to monitoring for and treatment to prevent possible myocardial infarction. If
the patient has a reduced left ventricular ejection fraction, then guideline-based
pharmacological treatment should also be initiated (e.g., -blocker, angiotensin
converting enzyme [ACE] inhibitor or both).
Stage C patients have structural disease and current or prior symptoms of HF,
such as shortness of breath, fatigue, and reduced exercise tolerance. These patients may
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benefit from all the above interventions. Additionally, diuretics may also be added to
their regimen. A cardiac rehabilitation program may be beneficial if symptoms warrant.
Stage C patients may require implantable cardioverter-defribillators (Hunt, 2005).
Finally, stage D patients have refractory HF. These patients require major
interventions as listed above and, possibly, biventricular pacing, cardiac
resynchronization therapy, or even heart transplantation (Hunt et al., 2005).
To summarize the four classifications of HF vary in severity from stage A in
which the person with HF can carry on most usual activities to stage D in which the
patient‘s functioning is so severely compromised as to require major or multiple
interventions to survive. If medical therapy has been maximized and the patient is unable
to tolerate a major intervention (or they have not succeeded), then at some point,
palliative care may be required to manage symptoms.
Psychosocial and Situational / Environmental Antecedent: Social Isolation
Nearly half of persons over the age of 85 years in the U. S. live alone
(Lichtenberg, MacNeill, Lysack, Bank, & Neufeld, 2003). However, social isolation is
not just living alone; it comprises perceptions that one is alone or without social networks
or social support. The North American Nursing Diagnosis Association (NANDA, 2000)
defines social isolation as aloneness experienced by the individual. Social isolation is
perceived as a negative or threatening state. Some defining characteristics include not
having interactions with close friends, neighbors, or family members. Other descriptors
include not having interactions with members of work groups or church groups. Social
isolation varies according to the degree of physical and emotional separation from other
people. While physical distance may be a predisposing factor, it is neither a necessary or
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sufficient condition for social isolation. A person can feel lonely and socially isolated
despite living in close proximity to significant others, and a person can live at some
physical remove from family, friends, and other supports yet not necessarily feel isolated,
alone, or lonely (Tomaka, Thompson, & Palacios, 2006).
For many elders, their usual social network of close friends may begin to diminish
because of ill health or death. In addition, elders may move to live with or closer to
family members, which may entail living further away from close friends and having to
adjust to a new environment and new routines
In Murberg‘s and Bru‘s (2001) research, 153 Norwegian elders participated in a
study to examine the influence social support and social isolation has on heart failure
patients. The sample was predominantly male, with men averaging 69.9 years of age, and
most were classified as NYHA category II heart failure. In Murberg‘s and Bru‘s research,
social isolation was assessed using four items: ―Do you feel the disease makes it difficult
to visit family and friends?‖ ―Do you feel that the disease makes it difficult to receive
visits from family and friends?‖ ―Do you feel the disease makes it difficult to participate
in social events?‖ and ―Do you feel that the disease makes it difficult to go on holiday
with family and friends?‖ The researchers found that there were significant associations
between social isolation and mortality among HF patients within a two year follow-up
period. The relative risk of mortality for a 1 point increase in social isolation score was
1.5 (95% CI 1.0 to 2.2, p < .04), after controlling for age, depression, NYHA class, and
atrial natriuretic peptide levels. Murberg and Bru also found that the lack of social
support from a spouse was more strongly related to fatal outcome compared with lack of
social support from a primary or secondary network.
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Research has shown that when elders face disability, they favor home and
community based settings, not institutional settings (Coleman, Kassner, & Pack, 1996).
Compared with white elders, minority elders have been found to prefer home and
community settings more strongly. This has been attributed to social cultural differences
in kinship relations or expectations of filial responsibility and differences in
socioeconomic status and access to services (Peng, Navaie-Waliser, & Feldman, 2003).
Social isolation and race or ethnicity. Living alone is not uncommon among
some groups. Peng et al. (2003) examined over twenty thousand records of patients
registered in the Outcomes Assessment Information Set (OASIS) between 1999 and
October 2000 and found that African American female elders were more likely than
Whites, Hispanics or Asian elders to be alone with no form of supportive care, either
formal or informal, after a hospitalization.
Hays and George (2002) used a prospective cohort study to describe race
differences among 4,132 elders to estimate ten year prevalence, incidence, and predictors
of living alone among Black or African American and White elders. The sample was a
stratified four stage random sampling of households from five counties in north central
North Carolina. Listing areas were stratified by racial characteristics to generate a sample
in which approximately 55 percent of the respondents would be African American and 45
percent would not. Hays and George found three out of every five elders lived with others
at the beginning of the study and continued to do so for the next 10 years or until their
death. Younger and better educated African American elders lived alone more frequently.
They also reported higher incomes, fewer biological children, and fewer living children.
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Hispanic elders commonly expect to live with family in old age (Tomaka, et al,
2006). Tomaka and associates telephone interviewed 765 Southwestern U. S. inhabitants
over the age of 60. Twenty three percent of the respondents reported their ethnicity as
Hispanic. According to Tomaka et al, it is well known that the family and extended
family play a central role in Hispanic culture and social lives. As such, one might expect
family support to play a particularly critical role in the health and well being of the elder
Hispanic (Tomaka, et al.). From a cultural perspective, as Hispanics assimilate to the
American culture, and young Hispanics move away from their nuclear families searching
for employment or educational opportunities, the elders may be left behind to live alone.
The number of Asian elders living alone has also risen, and there is scant research
addressing the mental health of those who live alone versus those who live with family
(You & Lee, 2006). Shih, Gau, Lo, and Shih (2005) studied the health needs of elders
living alone in Taiwan. Fifty four patients participated in the study; 48 were males and
61% of them (n=33) were unmarried. The principal diagnosis of 48% of subjects was
coronary disease. The unmarried male elders reported that a perception of powerlessness
occurred either in the preadmission or hospitalization stage or was expected to occur after
discharge. This group of Taiwanese elders living alone was found to have a low self
image and have greater needs from health care providers versus other elders who live
with their significant other (Shih et al).
Social isolation and gender. Social isolation also disproportionately affects
women. In 2003, 44.3% of women ages 65 or older were widowed; 78.3% of women
older than 84 were widowed and living alone (He, Sengupta, Velkoff, & DeBarros,
2005). In part, these statistics reflect the longer life expectancy of women compared with
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men in the U. S. However, there are also elements of choice. For example, it has been
reported that women with higher incomes chose to live alone more frequently than
women with lower incomes (Cheng, 2006).
According to Baker (2000), older Americans have the same desire for
independence as young Americans. Independence is equated with life itself.
Independence allows older adults greater autonomy to continue to define themselves and
avoid feeling they are a burden to others. Letvak (1997) studied eight women living
alone, all of whom expressed a desire not to change their life style. Living alone was
highly valued and equated with power, freedom, and making one‘s own decisions.
Bellin (2000) studied older women: these women reported combating loneliness
through prayer, working part time, keeping busy, and raising pets to decrease their
feelings of loneliness. Bellin‘s study also demonstrated that having to face difficult tasks
or health issues did not affect a woman‘s decision to live alone. In general, most women
found they could tolerate the feelings of being lonely. The risk for physical functional
decline and mental health problems may also be lower for women who live alone
compared with women who live with family members (Michael, Berkman, Colditz, &
Kawachi, 2001).
The most frequent related health problems reported by older women living alone
were hypertension, vision changes, arthritis, and incontinence (Austin, Devine, Dick,
Price, & Bruce, 2007). According to Austin and colleagues, falling was most concerning
to most women living alone. Older women also reported having their own ways to
maintain their health: staying active, eating right, getting enough sleep and using folk
medicines to relieve bothersome symptoms (Cheng, 2006). In White‘s (1997) study older
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women living alone had an increased use of hospital and community services. Bellin‘s
(2000) study demonstrated that most women did not receive care according to their actual
health status. This brings up an interesting point, that health, and isolation may be viewed
differently by the elder as compared to the health provider. Decreased use of services
may be due to income or transportation difficulties, not necessarily from noncompliance
or dissatisfaction with the provider-patient relationship.
Social networks are believed to have a beneficial effect, provide positive
interactional support, and affirmation that leads to an overall sense of self worth, self
esteem and positive affect. Social support is also believed to buffer the effects of stress
and disease (Lincoln, Chatters, & Taylor, 2005). In the stressful situations that occur
with disease, supportive networks can help an elder to reappraise and cope more
effectively with stressors.
Symptom Experience
In the TOUS (Lenz et al., 2005, 2007), symptom experience comprises both
individual symptoms and symptom clusters (See Figure 1). Among patients with HF,
symptoms of fatigue, dyspnea, and often, though not always, angina pectoris may also be
common. Depression is common, but often is not a symptom that patients explicitly
complain about to their health care providers (Frank, Asp, & Dahlberg, 2009).
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Figure 1: Theory of Unpleasant Symptoms; adapted from Lenz et al. (1997). (ANS:
Advances in Nursing Science, 19[3], 14 [Figure 1]. Used with permission, Lippincott
Williams & Wilkins).

Fatigue. Fatigue has been described by patients as a multidimensional
phenomenon involving physical mental sensations and affecting feelings that influence
functional ability (Ekman & Ehrenberg, 2002). The NANDA (2001) describes fatigue as
an overwhelming sustained sense of exhaustion and described capacity for physical and
mental work to occur at a person’s usual level. Defining characteristics of fatigue
according to NANDA also include:
a) The inability to restore energy even after sleep
b) Lack of energy or inability to maintain usual level of physical activity
c) Increase in rest requirements
d) Tired
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e) Inability to maintain the usual routine
f) Verbalization of an unremitting and overwhelming lack of energy
g) Lethargic listless
h) Perceived need for additional energy to accomplish routine tasks
i) Increased physical complaints
j) Drowsy
k) Feelings of guilt for not keep up with responsibilities
l) Compromised concentration
m) Lack of interest in surroundings
n) Decreased performance (NANDA, 2001, page 735)
Patients with chronic HF may become so accustomed to fatigue as a symptom of
HF that they may not mention it unless they are specifically asked. When a patient
complains of fatigue it is usually because it interferes with self care or the ability to
function normally. Friedman and King (1995) examined correlates of fatigue in older
women with HF and found that fatigue was the most frequently occurring symptom. It
has also been speculated that fatigue may be a contributing factor related to patients‘
inability to follow the prescribed treatment regimen. That is, patients are so fatigued that
they do not or cannot get up to take medications, or prepare the appropriate meals. Some
of the descriptors of fatigue are very similar to descriptors of depression: lethargy, lack of
interest in surroundings.
Dyspnea. Dyspnea is the second most prevalent symptom occurring among HF
patients. Dyspnea refers to sensations of unpleasant, uncomfortable breathing. It has been
defined as “a subjective experience of breathing discomfort that consists of qualitatively
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distinct sensations that vary in intensity....” that are derived “from interactions among
multiple physiological, psychological, social, and environmental factors, and may induce
secondary physiological and behavioral responses” (American Thoracic Society, 1999, p.
322). In heart failure, dyspnea may be the symptom that is most likely to prompt patients
to seek help (Mahler, Fierro-Carrion, & Baird, 2003). For example, dyspnea is the most
common reason for emergency department visits by patients with HF (Parshall, 1999).
Dyspnea has been examined using cluster analysis. That is, sampling patients of
known diagnoses and asking them to describe dyspnea. Among ambulatory HF patients
the three most consistent descriptors of dyspnea were found to be ―work/effort‖, trouble
exhaling, and trouble inhaling (Mahler et al, 2003). Others have described dyspnea as air
hunger (Peterson, Orth & Ritz, 2008). Parshall et al. (2001) found that HF patients,
recalling a specific emergency department visit, commonly referred to sensations of
―smothering,‖ ―choking,‖ and ―can‘t breathe‖ (p51). Among the chronic obstructive
pulmonary disease population dyspnea is commonly described in terms of work or effort
(Mahler et al., 1996). However, during periods of exacerbation, descriptors such as
smothering or suffocating are common (Parshall, 2002). People with asthma commonly
describe dyspnea in terms of tightness or constriction in addition to work or effort;
moreover, the sensations of tightness (which is thought to be primarily due to
bronchoconstriction) respond more rapidly to treatment with bronchodilators compared
with work or effort (which may persist, even after relief of bronchoconstriction due to
increased impedance from inflammation, which generally takes longer to resolve than
bronchoconstriction), hence tightness is mechanistically separable from work/effort
(Moy, Lantin, Harver, & Schwartzstein, 1998). Thus, qualities of dyspnea may vary not
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only by diagnosis but by the setting and context (e.g., whether patients are asked about
usual dyspnea or about a specific episode severe enough to lead to an emergency
department visit, or how breathing feels before, during, or after acute treatment).
Gift (1987) described acute dyspnea as having a rapid onset and chronic dyspnea
as being persistent or occurring over time. Gift argued that environmental stimuli,
situational factors and depression are factors affecting chronic dyspnea. She describes
people who cope with dyspnea as always being aware of intensity changes, living with a
fear of having a bout of dyspnea, and reducing physical activities accordingly. This
reduction in physical activities can lead one to reduce or cease altogether one‘s work,
social activities, or nonessential activities of daily living. The reduction in activity can
lead to deconditioning, worsening activity intolerance, social isolation and possibly
depression (Giardino, et al., 2010; Gift, 1993; Sassi-Dambron, Eakin, Ries, & Kaplan,
1995).
In a study of 57 HF patients who presented to an emergency room complaining of
dyspnea; 88% indicated their symptoms ordinarily interfered with activities that were
meaningful to them (Parshall et al., 2001; Welsh et al., 2002). The sample was
predominantly female (54%), and approximately 2/3 lived with others, but this was not
broken down by gender (Welsh et al.). The researchers described two general duration
profiles of dyspnea at presentation to the emergency department: those who had
experienced dyspnea for 3 days or less at approximately the same severity as when they
came to the emergency department , and those who had endured that severity of dyspnea
for at least one week before seeking medical assistance. However, there was no
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difference between these profiles in the percentage of patients admitted to the hospital
(Parshall et al.).
Depression. Under the TOUS, depression could be an antecedent factor (e.g., a
psychosocial pre-existing condition prior to a diagnosis of HF or even a risk factor for
cardiovascular disease), a consequence or outcome of other symptoms (e.g., reactive
depression in response to diminished functional capacity), or a symptom itself, either in
isolation or in a cluster with other symptoms (as is common in chronic conditions such as
HF). Because the nature of the proposed dissertation study is essentially cross-sectional,
it will not be possible to determine the extent to which depression, if present, may have
been a pre-existing condition or a symptom(s) outcome. Therefore, for the purposes of
this chapter it will be discussed as a symptom that may coexist with other HF symptoms.
Depression is one of the most common symptoms in the primary care setting and
the World Health Organization predicts that by the year 2020 major depression and
coronary disease will be the two leading contributors to the worldwide burden of disease
(Brody et al., 1998). The prevalence rate of depression ranges from 4.3 % to 26 % in
general populations (Kessler, 2004). Among the heart failure population depression has
been studied among outpatients, and the incidence rate has been reported to be as high as
42% (Skotzko et al., 2000).
Koenig (1998) found the prevalence of depression to be 36.5% in 543 inpatients
age 60 years or older. Romanelli, Faverbach, Bush, & Ziegelstein (2002) studied a group
of elders with recent myocardial infarction (MI). They found that almost one in four older
patients were depressed soon after an MI. Older patients with depression had a fourfold
increased risk of death within the first 4 months after an acute MI.
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Several biological factors have been examined and proposed as potential
mechanisms by which depression may lead to cardiovascular disease. One mechanism
that has been suggested is the dysregulation of the autonomic nervous system (ANS). In
early heart failure, cardiac sympathetic activation often predominates over vagal tone,
and norepinephrine levels are increased (Esler & Kaye, 2000), potentially increasing risk
for tachydysrhythmias. High levels of circulating catecholamines may contribute to
recurrent endothelial inflammation or injury, increased vascular and cardiac wall stress,
and increased platelet activation. Both inflammatory and platelet coagulant processes are
associated with depression (Esler & Kaye). Among patients with cardiovascular disease
there is evidence that altered autonomic tone associated with depression is associated
with increased heart rate and reduced heart rate variability. Carney et al. (2000) found
that there is a higher heart rate and a lower heart rate variability rate in depressed patients
with stable coronary disease compared with non-depressed patients with stable coronary
disease. The more depressed the patient, the lower the heart rate variability. They also
studied heart rate variability among patients with depression and found that cognitive
behavioral treatment of depression was associated with a decrease in heart rate of
approximately 5 beats per minute, but the effects on heart rate variability were equivocal.
Carney and colleagues concluded that their results were similar to those found when beta
blockers were administered to patients with coronary artery disease (i.e., a reduction in
sympathetic tone and decreased mean heart rate), especially during the day time.
Jonas, Franks, and Ingram (1997) studied a cohort of men and women for 7-16
years and found that there was an association between high anxiety and depression with
hypertension. The National Health and Nutritional Examination Survey I (NHANES)
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follow up study found that symptoms of depression at baseline were associated with a
higher risk of developing hypertension over a 20 year follow up (Mussolino, 2005).
Similarly, in the coronary artery risk development in young adults (CARDIA) study,
investigators followed over 1500 African-American and 1800 White men and women
patients for 5 years (Davidson, Jonas, Dixon, & Markovitz, 2000). They concluded that
depression was associated with hypertension. Depressive symptomatology was measured
using the Center for Epidemiologic Studies-Depression (CES-D) questionnaire (Radloff
et al., 1977) at the enrollment and at the 5 year period. Study patients with depression
scores greater than 16 at enrollment were significantly more likely to develop
hypertension during 5 years of follow-up.
Somatic awareness. Somatic awareness is the sensitivity to physical sensations
and bodily activity secondary to physiological change (Jurgens, 2006). HF patients are
asked to learn, recognize and to distinguish symptoms that need to be addressed or
reported on a daily basis (Grady et al., 2000). Somatic awareness in HF is made more
difficult by the daily fluctuations in symptoms of HF. Elders may experience symptoms
of HF, such as fatigue and dyspnea, but they may believe they are due to old age. When
the elder begins to “monitor” heart failure symptoms that are insidious, ambiguous, and
non-specific, uncertainty occurs, and with uncertainty comes hesitancy to report and a
delay in treatment may occur (Jurgens). Low somatic awareness is associated with
increased severity of coronary disease and longer delays in care seeking (Jurgens).
Symptom identification occurs when a person has a pattern, a certain degree of
familiarity with the symptom and has given the symptom meaning and a label (Mishel,
1988). The identification process has been shown to be delayed when persons have low
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somatic awareness (Dracup & Moser, 1997) or when a person begins to exhibit clusters
of symptoms (Ryan & Zerwic, 2003). A symptom cluster occurs when three or more
symptoms are experienced together, and the symptoms arise from various etiological
factors (Dodd, Miaskowski, & Paul., 2001).
Relatively little is known about symptom identification in HF; symptoms may
vary in number or severity and from stable to unstable over a relatively short interval,
often without obvious precipitating cause. Some may not seek assistance believing that
the symptom will resolve itself. Some HF patients consistently have a longer duration of
dyspnea, edema, cough, and orthopnea prior to hospital admission, suggesting that such
symptoms are relatively constant in number and severity or that these patients either
become inured to their symptoms or are unaware of their severity (Friedman, 1997;
Parshall et al. 2001).
Patients who are depressed in addition to having symptoms such as dyspnea and
fatigue may develop an attitude that their symptoms can‘t be helped. This is exemplified
among patients with end stage heart failure. This population has been reported to have
fewer social contacts, more limited support networks, and to be more noncompliant with
treatments. Zipfel, Lowe, and Paschke (1998) attributed the increase in depression
directly to psychological distress that is experienced in later stages of HF, particularly
among patients on a waiting list for a heart transplant.
Da Canhota and Piterman (2000) report that emotional and psychological distress
may not be spontaneously expressed by elders who may prefer to communicate only
physical symptoms. Often they may be abetted by health care providers who, in a busy
practice setting, may not inquire about psychological symptoms unless a patient or family
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member brings up the topic. This patient physician/provider communication breakdown
may lead to psychological symptoms being under treated and under reported among the
elderly. This communication breakdown may lead to treatment delay for symptoms of
HF. It is believed to be a factor associated with preventable hospital admissions (Vinson,
Rich, Sperry, Shah, & McNamara, 1990).
A number of reliable and valid questionnaires are available that can help to
determine if HF patients have secondary symptoms of depression or are experiencing
social isolation. A detailed description of the instruments to be used in this study is in
Chapter 3.
Outcomes
Readmissions and depression. Heart failure is a progressive, debilitating
disease. It is of no surprise that depression rates are high among this group. Jiang et al.
(2001) studied 374 heart failure patients 18 years or older, and assessed depression using
the Beck depression inventory (BDI). A total of 126 patients (35.3%) scored 10 or higher
(indicative of depression). Of the entire sample 40.2% had one or more readmissions.
Those experiencing major depression (n= 46) had the highest readmission rates at 3
months and 1 year. Persons with major depression had readmission rates of 52.2% at
three months. At one year the readmission rate was 80.4%. Persons with mild depression
had the next highest number of readmissions at 42.6%. at three months and 55.6% at one
year. Relative to the non-depressed (n=231), those with major depression were nearly
twice as likely to be readmitted at 3 months (OR =1.9, 95% CI 1.0 to 3.59, p =.04). Those
with major depression were 3 times more likely to be readmitted at the one year mark
(OR = 3.1, CI 1.4.- 6.66, p = .005). Patients with a BDI of 10 or higher had mortality
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rates of 11.9% at 3 months. At 12 months the mortality was 20.8%. Comparing patients
with BDI scores of ten or less the mortality rate was 5.7% at 3 months. At twelve months
the mortality was reported to be 13.7%. Also, in this study advanced age was associated
with increased mortality at 3 months (OR =1.05 for each 1year increase above age 63;
95% CI, 1.011-1.091, p = .01). NYHA class was not significantly associated with either
outcome at 3 months, but was associated with both outcomes at one year. The odds ratio
favoring death was 1.85 for each ascending class; 95% CI, 1.21-2.82, p =.05. The relative
odds favoring readmission were OR = 1.77 for each one stage increase in NYHA class,
95% CI: 1.25-2.53, p =.002.
Mortality and Social Isolation
Friedman, et al. (2006) studied the relationship between mortality and HF. In this
study, participants had NYHA class II or III heart failure and left ventricular ejection
fractions of less than 35%. Several instruments were used to assess various psychosocial
variables. The tool used to assess social support was the social support questionnaire 6
(SSQ-6). The SSQ-6 provides a list of six situations potentially requiring social support
and asks the respondents on whom they could rely for help, the amount of help, and their
perceived satisfaction with help in each situation. Individual item scores range from 0 to
1, with higher scores indicating more social support. The participants were predominantly
men, ranging in age from 35 to 85 years of age. Satisfaction with social support scores
ranged from 0 to 54 (Mean = 32.1, SD= 6.1). Mortality was 7% among patients above the
mean on social support and 14% among those below the mean. Mortality was 8% among
patients with high social support and without depression or anxiety, 16% for socially
isolated patients with either anxiety or depression, and 20% for socially isolated patients
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with both anxiety and depression. Both depression and social isolation were predictors of
mortality after controlling for demographic and clinical predictors of mortality. Friedman
and colleagues also found that the number of people the patients could ask for support in
specific situations was a predictor of survival, independent of demographic and clinical
status. Most importantly, the interrelationship of depression and social isolation is
consistent with HF outpatients living alone. Depression and social isolation are related to
mortality in this patient population: depression and social isolation predict mortality
independent of demographic and clinical status and perceived functional status
(Friedman, et al., 2006).
In summary, the TOUS demonstrates the complexity of psychological and
situational factors that may interact with symptoms. There is at least some indirect
evidence that readmission rates among patients with HF may be related to depressive
symptoms and social isolation. If depression or social isolation is found in this
dissertation study to be more severe or prevalent among readmitted HF patients compared
with those who are not readmitted, then it may be prudent to assess more systematically
for depression and social isolation during hospitalizations.
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Chapter 3
Methods
This chapter is divided into the following sections: 1) Specific Aims and Research
Questions; 2) Research Design; 3) Sample and Setting; 4) Variables and Measures; 5)
Protocol and Data Collection; and 6) Data Analysis.
Specific Aims and Research Questions
The specific aims of this exploratory study were to determine whether
readmission of elderly patients with heart failure was associated with differences in
depressive symptoms, social isolation, or both. The primary independent variable for the
study was 30 and 60 day readmission following discharge from an index hospitalization
for heart failure. For the dependent variables, depressive symptoms were measured using
the 15 item version of the Geriatric Depression Scale (GDS-15: Sheikh & Yesavage,
1986; Yesavage et al., 1983), and social isolation was measured using the 18-item version
of the Lubben Social Network Scale (LSNS-18; Lubben & Gironda, 2003). Hypotheses
for the study were: 1) patients readmitted within 30 and 60 days of discharge from an
index hospitalization for HF will have differed in depressive symptom scores (GDS-15
scores) during the index hospitalization from patients who are not readmitted; and 2)
patients readmitted within 30 and 60 days of discharge from an index hospitalization for
HF will have differed in social isolation (LSNS-18) scores during the index
hospitalization from patients who are not readmitted. Other patient characteristics to be
assessed in exploratory analyses included gender, race and ethnicity, age, educational
level, ejection fraction (preserved vs. reduced), NYHA classification, and b-type
natriuretic peptide level.
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Research Design
The study used a descriptive comparative design with prospective data collection.
The study was approved by the Committee for the Protection of Human Subjects at the
University of Texas Houston Health Science Center, and by the Memorial Hermann
Health Care System Center for Clinical and Translational Sciences. Informed consent
was obtained from all participants.
Those consenting to participate were screened for cognitive status with the MiniMental State Exam (MMSE; Folstein, Folstein, & McHugh, 1975), and those with
MMSE scores of at least 24 completed the GDS-15 and LSNS-18 during a hospitalization
for HF. Data were collected by interview and chart review. Following discharge,
participants were followed by checking readmission history on the daily census to
determine whether or not there was a readmission for heart failure within 30 or 60 days of
discharge. For both follow-up intervals, those who were readmitted for HF were
compared with those who were not in terms of their demographic characteristics, their
clinical characteristics during the hospitalization in which they enrolled (the index
hospitalization), and differences in GDS-15 and LSNS-18 scores during the index
hospitalization. There was no follow-up beyond 60-days.
Sample and Setting
Sample. The target population for this study was English or Spanish speaking
patients with heart failure (HF), aged 65 years or older. Informed consent was obtained
from all participants. Criteria for inclusion in the sample were: adults at least 65 years of
age admitted for a diagnosis of heart failure for which there was adequate clinical
confirmation (e.g., evidence of systolic or diastolic dysfunction by echocardiogram,
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nuclear scan, or cardiac catheterization, or evidence of a well-documented history of
heart failure). Participants had to be able to speak and understand English or Spanish.
Exclusion criteria were a history of dementia or substantial cognitive deficits or the
investigator’s judgment that an individual’s capacity for consent was diminished or
uncertain. A convenience sample of 120 participants was enrolled during an inpatient
admission for heart failure, but 12 were excluded for MMSE scores less than 24; one was
excluded after finding that a power of attorney (POA) for health care decisions had
previously been executed. Six persons who enrolled were discharged before completing
either of the study questionnaires, leaving a final sample of 101 participants who
completed at least one of the study questionnaires.
Setting. Participants were recruited from three large acute care hospitals that are
part of a single health care system in the greater metropolitan area of Houston, Texas.
One facility is centrally located and serves a large portion of the city indigent and
uninsured. The other two facilities are located in an economically stable urban setting.
Houston is the fourth largest city in the United States, and the state of Texas has the
fourth largest population of older adults (2.7 million). In Harris county alone, there are
424,000 persons residing who are over the age of 60 (Department of Aging and
Disabillity Services [DADS], 2007). Harris county also has a large older Hispanic and
African American population, 78,000 and 72,000 respectively.
The inpatient units where recruitment and data collection took place were a 45
bed cardiology unit with an average admission rate of 40 HF patients per month, and two
general medicine telemetry units with an average admission rate of 30 HF patients per
month. The facilities are part of the same multi-hospital health system. The investigator
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had an administrative position within the system, hence already had clinical privileges
and approved direct access to administrative and clinical data pertaining to admissions. In
addition, participants expressly consented to accessing records for purposes of
determining readmissions.
Variables and Measures
Demographic data. Demographic data were obtained both from the medical
record and the patient. For patients who gave informed consent to participate, identifiers
needed for the follow-up for readmissions included the patient’s name, medical record
number, and dates of hospitalization. Demographic data collected included age, gender,
income, ethnicity, marital status, and highest level of education. Clinical data obtained
from the medical record during the index hospitalization included admitting and
discharge diagnoses, ejection fraction, NYHA classification, b-type natriuretic peptide
(BNP) level within ± 24 hours of admission, etiology of HF (ischemic or non ischemic),
and medications prior to, during, and at discharge from the index hospitalization.
Medications of interest included beta-blockers, an angiotensin receptor blocker (ARB) or
angiotensin converting enzyme (ACE) inhibitor, nitrates, diuretics, and antidepressants.
Cognitive status. The presence of gross cognitive deficits or dementia was
determined during eligibility screening. Heart failure patients with documented dementia
or impaired decisional capacity (e.g., for whom a guardianship or durable power of
attorney is already operative) were peremptorily excluded without contact. Among
potentially eligible patients, the investigator used her expert clinical judgment during the
initial contact with the patient to determine whether the patient had adequate capacity for
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consent, and she excluded from participation any who, in her judgment, had questionable
decisional capacity.
Among patients who agreed to participate the mini mental state examination
(MMSE) was used to assess cognitive status (Folstein et al., 1975). The MMSE consists
of eleven items assessing orientation, recall, registration, attention, calculation, language,
and praxis. Scores range from 0 to30, with a score of less than 24 indicating cognitive
impairment. Participants scoring less than 24 were excluded from further participation.
Parker and Phillip (2004) found that people who belong to a minority group are at
greater risk than non minority persons of being misclassified as cognitively impaired
when, in fact, they are not. It has been demonstrated that older minorities who have not
assimilated to the U. S. tend to score lower than European Americans on the MMSE
(Espino, Lichtenstein, Palmer, & Hazuda, 2001). In particular, Hispanics who live in lowincome barrio neighborhoods are more likely to score lower than those in middle income
transitional or high income suburban neighborhoods (Espino et al., 2001). A Spanish
translation of the MMSE was used for Spanish-speakers, paying close attention to
differences in wording among various Latin American residents. Actual responses were
documented, rather than simply marking responses as correct or not.
Highest level of education is also a concern in testing with the MMSE. Wood,
Giuliano, Bignell, and Pritham, (2006) screened 323 African Americans and 91 Whites
with the MMSE and found that African Americans consistently scored lower than White
participants. The average years of school completed was less for African American
participants (M = 10.2, + 4.2 years) than for White participants (M= 11.7, + 4.1).
Problem areas of performance on the MMSE for African Americans included: 38% of
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African Americans participants could not complete the serial 7s item beginning at 100
and counting back by 7s, whereas only 19% of White participants could not complete it.
Twenty five percent of African American participants compared to 18% of White
participants had difficulty with copying the design on the MMSE (overlapping
pentagons). The most common missed items among African Americans on the MMSE
were the serial 7‘s, copy design, and the day of the week The serial 7‘s is a calculation
task, and copying a geometric design is a visual spatial task. Both involve mathematical
ability that is dependent on educational and cultural characteristics. The findings of the
Wood et al. study suggest that highest level of education should be assessed as part of the
baseline demographics, in addition to race and ethnicity.
Independent variable. The primary independent variable for the study was
whether or not a participant was readmitted for HF within 30 or 60 days of discharge
from the index hospitalization for HF. Determination of readmission status was
accomplished by review of administrative data and by contacting patients via telephone
to determine if they may have been admitted somewhere outside of the system.
Contacting patients proved to be difficult as many respondents did not answer their
phones or had answering machines. Because of privacy concerns, messages were not left
on answering machines.
Dependent variables. Geriatric Depression Scale-15. Depressive symptoms
were measured using the Geriatric Depression Scale (GDS)-15. The original Geriatric
Depression Scale (GDS) was designed specifically for screening depression in the elderly
(Yesavage et al., 1982-1983). In the initial testing, Cronbach’s alpha for the GDS was
.94, which was comparable to the Zung Self-Rating Depression Scale (SDS;
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= .87) and

Hamilton Rating Scale for Depression (HRS-D;

= .90). The median corrected item-

total correlation for the GDS was r = .56 (range 0.32-0.83). The mean inter-correlation
for the GDS items was r = .36. The GDS was concurrently valid in relation to the HRS-D
and the SDS, as well as with the number of depressive symptoms as determined by
Research Diagnostic Criteria for depression (Yesavage et al.) All three of these scales
discriminated significantly between normal (non depressed), mildly depressed, and
severely depressed elderly, F(2, 97) = 99, p < .001, and all three scales discriminated
significantly across all three pairwise comparisons by post hoc pair wise t-tests (p < .001
for all comparisons; Yesavage et al.)
The scale that was used in the present study was the fifteen item short version of
the GDS (GDS-15) (Sheikh & Yesavage, 1986). The short form is correlated significantly
with the long form, r = 0.84; p < .001 (Sheikh & Yesavage) and internally consistent
(Cronbach‘s
al., 2005;

= .80, D‘Ath, Katona, Mullan, Evans, & Katona, 1994;

= .79, Koehler et

= .78, Weeks, McGann, Michaels, & Pennix, 2003). D‘Ath et al. (1994) also

found the area under the receiver operating characteristic curve (ROC) against a criterion
diagnosis of depression was 0.73 for the 15-item version compared with 0.79 for the 30
item version. D‘Ath et al. concluded the 15 item scale was an adequate substitute for the
full 30-item scale.
The geriatric depression scale has been used with HF patients in outpatient
(Koenig, 2006) and in acute care inpatient settings (Fulop, Strain & Stettin, 2003). In one
acute care setting Weeks et al. (2003) evaluated 816 HF patients for depression using the
GDS-15. The GDS-15‘s internal consistency reliability was marginal (Cronbach‘s
.72).
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As with the full version, the GDS-15 discriminates between depressed and non
depressed elderly (Sheikh & Yesavage). The GDS-15 is available in both English and
Spanish (Carrete et al., 2001). The GDS-15 uses a dichotomous response (yes/no) format
for each item. There are no negatively worded items. Ten of fifteen items when answered
affirmatively indicate depression; whereas five items indicate depression if answered in
the negative and are reverse-scored before calculating reliability estimates or a total
score. The higher the score on the GDS-15, the greater the number of depressive
symptoms. Sheikh & Yesavage (1986) recommended a criterion of 5 or greater as
indicating the potential presence of depression when using the 15 item scale; however, in
other studies, cut points have ranged from 4 to 7 (Wancata, Alexandrowicz, Marquart,
Weiss, & Friedrich, 2006).
A potential limitation of a dichotomous response format is that some people may
have a tendency toward only positive or negative answers, irrespective of the question
(Streiner & Norman, 2003). However, dichotomous items are often preferred by older
respondents (i.e., compared with ordinal or continuous item scale types; Yesavage et al,
1982-1983). Another reason for preferring the GDS-15 scale for the elderly is that it does
not contain somatic symptoms which can be related to physical disorders that may be
common in the elder population, not just depression e.g., loss of appetite, loss of energy,
and fatigue (Alexandrowicz et al., 2006). Also the GDS scale does not ask questions
related to long term outlook on life, which may not be appropriate for all elderly persons
(e.g., near the end of life). Another advantage of the GDS-15 is brevity and ease of
completion- approximately 5-7 minutes (Sheikh & Yesavage, 1986).
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Wancata et al. (2006) conducted a systematic review of both the GDS 15- and the
30-item version (21 studies and 32 studies, respectively). The pooled sensitivity of the
GDS-15 was 0.805 and specificity was 0.750 against a valid criterion measure or
diagnosis of depression. These were comparable to the GDS-30 (.753 and .770,
respectively; Wancata et al.). In studies in which the Center for Epidemiological Studies
Depression (CES-D) scale was used in addition to either or both versions of the GDS
against a valid diagnostic criterion for depression, both versions of the GDS were more
sensitive and less specific than the CES-D, but the differences were not large (Wancata et
al.). Overall, Wancata et al. concluded that the criterion-referenced validity of either
version of the GDS was comparable to the CES-D (Wancata et al.).
The GDS was translated by a group in Spain (Ramos Brieva, Montejo Iglesias,
Lafuente Lopez, Ponce de Leon Hernandez, & Moreno Sarmiento, 1991). They found
that one particular question, which asks, ―Do you prefer to stay at home, rather than
going out and doing new things?‖ was consistently answered as yes in certain cultures.
They speculated that normal daily life of elders in certain populations may involve
staying at home. They recommended that the cut point might need to be adjusted for
different populations. For Chinese and Turkish versions of the GDS the same question
was correlated with depression, but the respondents themselves did not view their answer
as being indicative of depression (Chan, 1996; Ertan & Eker, 2000).
Carrete, et al. (2001) translated and validated a Spanish version of the GDS-30.
Using a random sample of 252 ambulatory Argentinean patients, they compared their
GDS translated telephonic version (GDS-T) with the same scale administered two weeks
later in a face to face interview. The face to face interview consisted of two parts. First an
54

interviewer conducted the history and physical, determining activities of daily living,
instrumental activities of daily living, and a mini mental state examination. A different
interviewer, blind to the previous results, administered the GDS in person (GDS-P).
Carrete et al. reported item to item correlations between the two versions ranging from
0.32 to 0.85. Of the 169 elders who followed up with the person to person interview
Carrete and associates reported a Cronbach‘s

coefficient of 0.85 (GDS-P) and 0.88 for

the GDS-T. Sensitivity and specificity were 88% and 82%, respectively for the GDS-P,
and 84% and 79%, respectively for the GDS-T.
In Texas, Baker and Espino (1997) translated and assessed the reliability of the
GDS-15 among Mexican Americans with known DSM –III-R psychiatric diagnoses. In
this sample 23 men and 18 women ranging in age from 62-98 were screened. Then the
elders were divided into two groups: those with major depressive disorders (n=28) and
those with other DSM-III-R depressive disorders (n=13). In this sample the GDS-Spanish
scores ranged from 1-14. When the cut point for depressive symptoms was a score
greater than 5, the sensitivity for major depressive disorders group (MDD) was only 39%
(11 of 28 screened positively for symptoms of depression). Among the other depressive
disorders (ODD) group 10 of 13 (Sensitivity = 77%) screened positively for depressive
symptoms. When the cut point was lowered to a score of 4 or greater, the sensitivity
improved to 75% for MDD (21/28) and 85% (11/13) for ODD.
Fernández-San Martín et al., (2002) translated the GDS-30 into Spanish. The
internal consistency of the GDS (Cronbach‘s ) was .82. In this study 14% of the
subjects were illiterate and 50% had received no education. The comprehension of the
questions was believed to be high.
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The translated version that was used in the present study was the Spanish version
by Fernández-San Martín et al. This version was selected because the Spanish translated
version is estimated to be at a sixth grade level by facility translators for the health care
system where the study was conducted. Translators used the Fernandez-Huerta
Readability Calculator (n. d.), which estimated the readability level, not syllable count
and determined the GDS was easy to read. Only the GDS-15 questions will be selected
from the GDS- 30 Fernández-San Martín et al. version (Appendix B); the same 15 items
were used by Baker & Espino (1997).
In the present study, participants scoring greater than or equal to 5 were
considered positive screens reflecting depressive symptomology (Meara, Mithelmore, &
Hobson, 1999; Sheikh & Yesavage, 1986). The admitting physician was notified via
progress note if persons were reporting symptoms of depression or scoring a five or
higher.
Lubben Social Network Scale. Measurement of social isolation was with the 18item version of the Lubben Social Network Scale (LSNS; Lubben scale; Lubben &
Gironda, 2003). The LSNS is a brief self reported inventory designed to gauge social
isolation in older adults by measuring perceived social support received by family and
friends. It was developed in 1988 and revised in 2002. The original version (Lubben,
1988) was a ten item scale. It consisted of an equally weighted sum of 10 items used to
measure size, closeness, and frequency of contacts of a respondent’s social network.
Items are rated using Likert-type scoring with 5 ordinal response categories. The revised
scale consists of an equally weighted sum of 18 items used to measure size, closeness and
frequency of relatives, friends, and neighbors (LSNS-18; Lubben et al., 2006). The longer
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version has three separate subscales for friends, family, and neighbors and has the highest
level of internal consistency alpha 0.82 for the total score (Lubben & Gironda, 2003).
The subscales for friends, family, and neighbors can be used to determine whether major
differences in network characteristics exist between groups.
The LSNS-18 is computed by summing the 18 items with total scores ranging
from 0-90. Lower scores indicate smaller networks (Lubben & Gironda, 2003). However,
one validation study by Rutledge, Matthews, Lui, Stone and Cauley (2003) found that the
Lubben possessed poor internal consistency levels ( = 0.55). Scores lower than 36
reflect social isolation (Emlet, 2006). The physician was notified via progress note if a
patient‘s score was 36 or less, possibly reflecting social isolation.
Protocol and Data Collection
Prior to data collection the protocol for this study was approved by the Committee
for the Protection of Human Subjects at the University of Texas Houston Health Science
Center and by the Memorial Hermann Health Care System Center for Clinical and
Translational Sciences. The researcher also met with the Cardiology Division Chiefs and
administrative directors to explain the study and seek general approval and support.
Recruitment and consent. The procedure for recruiting patients involved
acquiring a daily census with a working diagnostic code (DRG) indicative of heart
failure. The investigator had access to census and admitting data by virtue of her
employment position in the health care system. Once the patient was identified, the
admitting orders were checked to verify the diagnosis. The patient’s physician was
approached and permission was obtained to approach the patient.
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Next, the nurse taking care of the patient was asked if the patient was awake, alert
and oriented. If yes, then the patient was approached and asked if he or she would like to
participate. At this time the study was explained and questions answered. Patients who
expressed interest in possibly participating were given consent form (Appendix E or F)
and HIPAA forms (Appendix G); these were explained and the patient was asked to read
them or have them read. Patients were given reasonable time to read and consider
whether or not they wished to agree to participate. Signed informed consent was obtained
from patients who agreed to participate. The original was placed in the medical record in
the consent section; a copy was maintained by the investigator. A third copy was given to
the patient.
After consent was obtained, the researcher administered the questionnaire packet
beginning with the mini mental state exam (MMSE). If the patient scored at least 24 on
the MMSE, the LSNS-18 and the GDS-15 were then administered. A progress note was
written explaining the scores; it was then up to the discretion of the provider to determine
if a referral was needed.
After discharge the patient was followed in the readmission database, an
electronic administrative record, for up to 60 days. The investigator had access to these
administrative data by virtue of her employment position, and participants explicitly
consented to that access. In addition, when the readmission telephone call was made,
participants were asked if they had been admitted to an outside facility. The follow up
period was divided into two 30 day intervals, and the focus of the study was on how
many patients were readmitted at least once in either period, not on multiple
readmissions.
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Data Analysis
Statistical power and sample size were estimated by a biostatistician using PASS
software, based on a preliminary review of administrative data for the three study
hospitals suggesting an overall 30-day readmission rate of .20. To date, no studies using
the LSNS have been conducted with patients with HF; therefore, estimates were based on
the GDS-15 which has been used in HF and other chronic diseases. Because readmission
is dichotomous, initially, the approach taken was to estimate power and sample size for
an odds ratio of 2.0, assuming a 20% readmission rate and a median split on the GDS-15
as predictor (i.e., a relatively large effect size), but the sample size requirements for a
power of at least .80 were prohibitive for a dissertation study (N ≈ 400 overall, ≈ 200
each, above and below the median on the GDS-15), given the expected acuity of a
hospitalized HF population.
Therefore, the approach taken for purposes of sample size and power estimation
(and, hence, for the data analysis plan) was to treat readmission as a dichotomous
independent variable and the GDS-15 scores during the index hospitalization as the
dependent variable. For a range of standard deviations, consistent with published reports
on the GDS-15 in HF and other chronic diseases (2.0-4.0 points), a sample size of 120
was sufficient for power > .80 to detect a mean score difference of at least 2.6 points on
the GDS-15 using a two-tailed two-sample t-test at a significance level of p< .05.
Because the overall expected readmission rate was relatively low (.20), the expected
number of readmissions in a sample of 120 was only 24. If the actual rate were lower,
enrollment would continue to a minimum of 20 readmission events.
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Data analysis was conducted using PASW Statistics (Version 17). Data were
screened for accuracy of data entry and missing data by the researcher. Descriptive
statistical analyses included frequencies and proportions or percentages for categorical
variables (nominal or ordinal), means and standard deviations for continuous (interval or
ratio) level data that are at least approximately normally distributed, and medians with
interquartile ranges for continuous variables that are not normally distributed (or ordinal
variables with > 7 categories).
Analyses of bivariate associations include chi-square analyses for nominal
variables and parametric (Pearson product moment) or nonparametric (Spearman rank
order) correlation coefficients according to the level of measurement and distributional
characteristics of variables at an ordinal, interval, or ratio level of measurement.
The GDS and LSNS scales were analyzed for inter item and adjusted item-total
correlations and assessment of internal consistency (Cronbach‘s alpha for the LSNS and
the Kuder-Richardson variant [KR-20] of Cronbach‘s alpha for the GDS-15). Item
analysis was conducted with the goal of achieving a minimum alpha (or KR-20) of 0.80
which Nunnally and Bernstein (1994) describe as sufficient for an already developed
instrument.
Initially, two-tailed, two-sample t-tests were used to determine whether
participants who were readmitted within 30 or 60 days differed from those who were not
in their GDS-15 and LSNS-18 scores during the index hospitalization. Two-way analysis
of variance with fixed factors was used to determine if there was any interaction between
gender and readmission status. Contingency table methods were used to determine
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whether there was a significant association between readmission and the proportions of
participants above and below the respective cut points of the GDS-15 or LSNS-18.
Protection of Human Subjects
The study was approved by the Committee for the Protection of Human Subjects
at the University of Texas Houston Health Science Center and by the Memorial Hermann
Health Care System Clinical Innovation and Research Institute. Once site and IRB
approvals were obtained, meetings were held with care giving staff in the units where
data collection occurred. The purpose of these meetings was to explain the general
purposes of the study to the staff and to secure their cooperation. Actual recruitment and
consenting were the responsibility of the investigator, but care giving staff were asked to
confirm that a patient was sufficiently stable to recruit or to facilitate introducing the
investigator to the patient.
The consent addressed: a) study title, b) sites of study, c) name and telephone
numbers of investigator, d) purpose of study, e) description of study, f) benefits to
respondents, g) risks to respondents, h) alternatives to participation in the study, i) subject
withdrawal j) subject‘s right to refuse, k) subject‘s right to privacy, l) release of
information, m) financial information, and n) acquisition of signatures. Consent also
authorized the investigator to use administrative data for purposes of determining if there
were any readmissions for heart failure within 30 or 60 days of discharge from the index
hospitalization.
As this was an observational study, there were no direct benefits to participation.
Risks and discomforts of participation were not beyond those ordinarily experienced in
inpatient clinical interviews, and mechanisms were put in place for notification of a
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participant‘s physician if scores on either the GDS-15 or the LSNS-18 were indicative of
a potential problem.
A copy of the consent was given to each study participant. A locked filing cabinet
containing study information was maintained by the investigator in the hospital facility,
in the department of performance improvement. The office was secured when the
investigator was not present. Results will be communicated only in aggregate, with no
identifying information to be reported.
In terms of confidentiality, all participants were given an anonymous study
identifier number at enrollment. It was necessary for the duration of the study to maintain
specific identifiers of the participant‘s name, medical record number, and dates of
hospitalization. These were maintained on a separate face sheet to the demographic data
record. Any data entered electronically into a database or statistical program used only
the anonymous study ID number, not the patient‘s name or medical records number, and
only the LOS in days, not the actual dates of hospitalization. At the completion of the
study, the face sheets were removed and shredded, at which point the only record of
participants‘ names were the consent and HIPAA forms, which do not have the study ID
number on them.
Summary
It is hoped that this study will add to the body of knowledge about readmissions
for heart failure exacerbations. Patients who are sometimes labeled as ―frequent flyers‖
may represent failures to recognize a potentially treatable comorbidity (depression) or
problems with social support, either of which could begin to be addressed during an
index hospitalization, and both of which have implications for case management. For
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example, for hospital case managers or social workers, it may signal that more
community-based nursing case management may be needed to assist this group of
patients in the effective treatment of their heart failure. An acute hospitalization episode
is an opportunity to begin appropriate screening and to make appropriate referrals. The
use of short, quick, reliable assessment tools may assist in this preventive role and may
help reduce hospital readmissions for this population.

63

Chapter 4
Results
This chapter will present the results of the data analysis in the following sections:
descriptive statistics for demographic and clinical characteristics and for readmission;
results pertaining to the research questions; and exploratory analyses.
Between January 2009 and August 2009, to reach the target sample size of 120,
physicians were contacted about potentially eligible patients on 200 occasions. On 130
occasions, physician permission was granted and patients were contacted. Ten of those
patients declined participation. Of the 120 participants who were enrolled in the study, 12
had MMSE scores under 24 and one was subsequently excluded due to an existing power
of attorney(n = 13 excluded). A total of 7 were discharged before completing all study
measures, but 101 (84.2% of all who enrolled) completed at least one of the two study
questionnaires (n = 101 for the GDS-15; n = 100 for the Lubben scale). Descriptive
demographic and clinical data will be given for all participants who completed at least
one of the questionnaires (N = 101).
Descriptive Statistics
Demographic characteristics. The participants were age 65 or older hospitalized
for treatment of heart failure in one of three acute care hospitals of a multi-hospital
network in a metropolitan area in southeast Texas. Upon admission, the preliminary or
working diagnosis was HF as identified by the charge nurse, case manager, or patient‘s
nurse. Only one participant (with preserved ejection fraction) had a principal discharge
diagnosis other than HF (myocarditis); this participant was not excluded because
myocarditis is associated with dilated cardiomyopathy, and acute inpatient treatment for
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myocarditis is generally similar to treatment for heart failure (Cooper, 2009). Data on
gender, race and ethnicity, and educational attainment are summarized in Table 1.
Table 1
Demographic characteristics of sample (N = 101)
Variable

Frequency (%)

Sex
Male

50 (49.5)

Female

51 (50.5)

White

46 (45.5)

Black/African-American

41(40.6)

Hispanic

14 (13.9)

Race / Ethnicity

Education
< 8th grade

6 (5.9)

9th -12th

54 (53.5)

Some college

29 (28.7)

College Graduate

11 (10.9)

Did not answer

1 ( 1.0)

There was no substantial difference in race, ethnicity, or educational status by
gender, but there was a very substantial difference in marital status by gender (Table 2).
Nearly 2/3 of the men were currently married compared to approximately 30% of the
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women,

2

(df = 3) = 17.32, p < .001;

= 0.41. Other than that, there were no striking

differences in other demographic characteristics according to gender.
Table 2
Marital Status by gender (N = 101)
Variable

Frequency (%)

Marital Status
Male (n = 50)

Female (n = 51)

Currently married

32 (64)

15 (29)

Not currently married

18 (36)

36 (71)

Compared with those who did not complete at least one of the study
questionnaires (n = 6), those who were excluded (n = 13) were more likely AfricanAmerican or Hispanic (1/6 vs 12/13, Fisher Exact Test p = .003). There was no
significant difference between those who completed at least one of the study
questionnaires (n = 101) and those who were excluded (n = 13) in gender, age, marital
status, education, EF (preserved vs diminished), or LOS. Those who were excluded were
more likely to be African-American (8/12; 67%) or Hispanic (3/12; 24%) than those with
a MMSE of at least 24 who completed at least one of the study questionnaires (41% and
14%, respectively),

2

(df = 2) = 7.26, p = .026,

= 0.25.

The mean (SD) age of the participants was 76.3 (7.6) years. The median was 77
and the mode (n = 12) was 80 years of age. Age ranges by decade are shown in Table 3.
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Table 3
Age ranges of participants (N = 101)
Age Range

Frequency (%)

65-74

43 (42.6)

75-84

44( 43.6)

> 85

14 (13.9)

Clinical characteristics. Length of stay (LOS) for the index admission (Table 4)
ranged from 1-29 days for the initial hospitalization and was markedly skewed in a
positive direction and extremely kurtotic. The median LOS was 4 (25th %ile = 3, 75th
%ile = 7) days and the mode (n = 101) was 3 days. Approximately 16% (n = 16) had a
LOS of 10 days or longer. One participant died before discharge. Length of stay did not
differ between men and women and had only a weak positive correlation with age that
was not statistically significant (Spearman rank-order correlation, rs = .18, p =.07).
Table 4
Length of stay (LOS) for enrolled sample (N= 101)
LOS in days

Frequency (%)

1-3

37 (36.6)

4-6

36 (35.6)

7-9

12 ( 11.9)

> 10

16 (15.8)

67

Fifty five percent of participants (n = 56) did not have a b-type natriuretic peptide
(BNP) ordered within 24 hours of admission. For the other 45 participants, BNP levels
ranged from 33 -16,847 pg/ml, median = 939 (25th %ile = 581; 75th %ile = 3480). The
only BNP value less than 100 pg/ml was from a patient with myocarditis. Only one
patient, with unspecified heart failure, had a BNP value greater than 11,000 pg/ml. The
BNP distribution was positively skewed and extremely kurtotic.
Left ventricular ejection fraction (LVEF) ranged from 10 to 75 percent. The range
for men (n =49; 1 not documented in chart) was 10% to 55%; for women (n = 51), the
range was 19% to 75%. Median (25th, 75th %ile) was 34 ( 25, 40) for men and 34 ( 25,
45) for women. Approximately 14% of men had preserved ejection fraction (> 40%)
compared with 29.4% of women. (Table 5)
Table 5
Left ventricular ejection fraction by sex (N = 100)
Men (n = 49)
n (%)

Women (n = 51)
n (%)

<20%

9 (18)

5 (10)

21-25%

9(18)

8 (16)

26-30%

6 (12)

3 (6)

31-35%

9 (18)

10 (20)

36-40%

9 (18)

10 (20)

>40%

7 (14)

15 (29)

Range

A higher proportion of men (86%) than women (71%) had an ejection fraction
less than 40%, but overall, there was no significant difference by sex across categories of
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ejection fraction,

2

(df=5) = 5.18, p = .39,

= .23 or by whether LVEF was preserved (>

40%) or not, Fisher exact test, p = .09. Neither BNP nor LVEF was correlated
significantly with LOS, rS < .20. BNP was negatively correlated with LVEF, rS = -.35, p
= .016.
The principal discharge diagnosis occurring most frequently was unspecified
heart failure (n = 35). The next most frequent was acute-on-chronic systolic heart failure
(n = 24; Table 6).
Readmissions. Readmission within 30 and 60 days of discharge was assessed for
all participants with complete data on at least one study questionnaire (N = 101). During
the 30 day study period, there were a total of 27 patients (27%) who were readmitted for
HF. By 60 days, there were an additional 8 readmissions, but 4 were among patients who
were also readmitted within 30 days. Therefore, a total of 31 patients (30.6%) were
readmitted within 60 days. Readmission was more common for men than women (Table
7), but the difference was not statistically significant at 30 days or 60 days. The
participant whose discharge diagnosis was myocarditis was not readmitted at 30 or 60
days.
At 30 days all patients received a follow up phone call to ask if they had been
admitted to an outside facility. The majority of the respondents did not answer the
telephone or had answering machines. To be HIPAA-compliant, phone messages were
not left for the participants. Only 15 participants were successfully contacted by phone;
none had been readmitted.
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Table 6
Discharge diagnosis (N=101)
Diagnosis

ICD-9

Frequency

Unspecified HF

428.0

35

Acute-on-chronic systolic HF

428.23

24

Chronic systolic heart failure

428.22

7

Acute systolic heart failure

428.21

6

Chronic diastolic heart disease

428.32

5

Acute-on-chronic diastolic HF

428.33

5

Acute-on-chronic combined systolic and diastolic HF

428.43

4

Unspecified systolic HF

428.20

4

Acute diastolic HF

428.31

3

Chronic combined systolic heart failure

428.42

2

Rheumatic congestive HF

398.91

2

Hypertensive heart and chronic kidney disease

404.00

1

Hypertensive heart and kidney disease with HF

404.93

1

Unspecified diastolic heart failure

428.30

1

Myocarditis

429.00

1

Total

101
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Table 7
Readmissions (N = 101)
Readmission

Male (n = 50)
n (%)

Female (n = 51)
n (%)

≤ 30 days

16 (59)

11 (41)

< 60 days

19 (61)

12 (39)

Geriatric Depression Scale
The GDS was completed by 101 participants. The mean GDS score was 2.7 (1.7)
points. The median and mode were both 3. Only 9 participants had scores greater than or
equal to 5, consistent with at least mild depressive symptoms. This probably reflects a
selection bias that likely is attributable to several unanticipated factors. Physicians were
less willing to permit the researcher to approach patients who were more seriously ill and
who may have been more depressed. In addition among those who were approached,
those who were more depressed may have been less inclined to participate.
Among participants, there was no significant difference between men and women
in GDS scores. The median (25th, 75%ile) for women was 3 (2, 4) points; for men, it was
2 (1,4) points, Mann Whitney test, mean rank 54.25 for women and 47.69 for men,
z = -.1.14, p = 0.25). There was no significant difference by age group in GDS scores,
Kruskal-Wallis

2

(df = 2 ) = 1.60, p = 0.45. Mean ranks were 51.1, 48.27, and 59.4, and

medians were 3 (2, 3), 2 (1, 4), and 3 (2, 4), respectively for the 65-74, 75-84, and 85
years or older groups.
The Kuder-Richardson-20 statistic (equivalent to Cronbach‘s alpha for
dichotomous items) was only 0.39 in this sample and the mean interitem correlation was
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nearly 0 (mean = .04; range = -0.17 to + 0.31). This probably reflects a floor effect on
scores (~ 91% < 4 points). Because of the low reliability estimate, it was not possible to
test the hypothesis that participants who were subsequently readmitted were more
depressed at the time of the initial hospitalization. In an exploratory analysis, participants
with scores of five or more (n = 9) or 4 or more (n =30 ) were not significantly more
likely to be readmitted at 30 or 60 days, Fisher exact test, p > .05.
The Lubben Scale
The Lubben scale was completed by 100 participants. The mean score in this
study was 48.3 (SD 11.7), the median was 47.5 (25th – 75th percentiles: 40.0-55.8).
Overall, thirteen participants (13%) had scores less than 36. Scores were normally
distributed, Kolmogorov-Smirnov test, p =.20
Overall, the Cronbach alpha for the Lubben was 0.77, indicating that about 23 %
of the total item variance was attributable to measurement error (DeVellis, 2003). The
mean inter-item correlation was low (mean r = .15, range -.25 to .65). Corrected itemtotal correlations ranged from 0.03 to 0.59, and squared multiple correlations from 0.22
to 0.61. Only one item if deleted would have increased alpha, but only marginally (#3,
―How many relatives do you feel at ease with to talk about private matters?‖) Deletion of
this item would have raised Cronbach‘s

to 0.785). Overall, internal consistency

reliability was adequate for purposes of hypothesis testing.
To test the hypothesis that those who were readmitted at 30 or 60 days had lower
Lubben scale scores than those who were not readmitted, a two sample t test was used.
There was virtually no difference in Lubben scale scored between those who were or
were not readmitted at least once within 30 or 60 days. At 30 days post discharge, the
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mean score (SD) for patients who were readmitted was 47.3 (SD 10.1) versus 48.7 (SD
12.3), t (df = 98) = 0.53, p = .60. The mean score for those readmitted at 60 days was
48.3 (SD 10.4) versus 48.3 (SD 12.3) for those who were not readmitted, t (df = 98) =
-0.03, p = .98.
Exploratory analyses were conducted to examine if there were significant mean
differences between Lubben scores for men versus women, and to determine if there was
any interaction between sex and readmission. In a two-way ANOVA with interaction
term (gender, total admissions, gender x total admissions) there was no interaction
between sex and readmission, F(1,96) = .18, p = .67. The model without interaction
showed no significant difference in Lubben scores between men and women, F( 1,97) =
.03, p = .87.
Several issues relevant to the wording of items of the Lubben scale emerged
during data collection. Many participants asked for clarification with questions related to
the wording, ―How often do you see or hear from relatives, friends or neighbors?‖
Participants wanted to know if email counted as ―hearing from‖. The same was true of
the series of questions asking, ―How often do you see or hear from relatives, friends or
neighbors with whom you have the most contact?‖ More than 50% of participants were
using email with some frequency. The Spanish translation of the Lubben had one word,
pariente, for which Hispanics in this sample nearly always requested clarification. In
general, parientes means a relatives or relations. Familares (i.e., family members)
appeared to be a more common word among Hispanic participants.
Several questions on the Lubben scale tended to elicit more expansive responses
beyond just marking the Likert-type rating. With regard to question 7: How many
73

neighbors do you see or hear from at least once a month? Nearly all participants
indicated they had 3 or more neighbors. However, four participants indicated that they
were referring to neighbors from their past residences because they had recently moved
to the city and actually knew no one outside of their immediate family. These four
participants were married and had moved to be with a daughter or son. All four had a
poor prognosis and felt that the surviving spouse would have an easier time being in close
proximity to a son or daughter.
Questions 9 (How many neighbors do you feel at ease with that you can talk to
about private matters?) and 10 (How many neighbors do you feel close to such that you
could call on them for help?), though similar in wording, elicited differing responses. The
predominant response to Question 9 was none. However, African-American and Hispanic
participants were somewhat more likely to respond that they felt at ease with one or two
neighbors.
In answering these questions, many participants recalled a time when they knew
their neighbors well, could talk with them and rely on them for help. Many participants,
in contrast, indicated that nowadays they rarely knew their neighbors well. Some noted
that their neighbors were younger and appeared too busy to talk, so they did not try to
have a friendship with them. Widowed or divorced participants, however, indicated that
they tried consistently at least to talk to neighbors.
Even though they did not necessarily confide in neighbors, most participants had
at least two consistent persons they could rely on for help. Widowed women in particular,
told stories about partnerships they had with neighbors to keep an eye on their property.
One stated that her neighbor knew that if the front window blinds were not open, then
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something might have happened to her. The neighbor then knew to go ring the door bell
or call her and check on her. Another woman described how she and her next door
neighbor had a pact: if her newspaper was not picked up by 9am, (which was the time he
went to work) then he was to call the police to summon help. Another woman had an
understanding with neighbors that she moved her car out of the garage to the driveway
every morning and back inside the garage by 5 pm. This signified that all was well.
Several neighbors knew they needed to call for help if the car was out past dark. Two
women had emergency response alarms that they wore around their necks.
One divorced male participant, living in a trailer park, had two friends he could
call on for help. Additionally, they had given him an air horn to use when his breathing
became difficult. His neighbors could easily hear the horn, and they would arrive or other
nearby neighbors would arrive to help him. His neighbors also rotated cooking meals for
him all year long. Another single male veteran reported having one neighbor he could
call on for help. Unfortunately he had to pay the neighbor (out of his retirement money)
to assist him with his activities of daily living. When asked why he had not solicited
assistance from the Veterans Department, he stated he would not take charity. After a
long emotional discussion, this veteran finally agreed to talk with social services and he
received emergent assistance.
One divorced female, when asked how many neighbors she could call, said she
could call on two neighbors, but felt they could not assist her. Her house had lost part of
the roof and every time it rained she had water in her kitchen. Also, rats were coming in
through the roof. Her two small dogs would fight off the rats, but, she was so afraid to
fall asleep in the bed and get bitten by the rats, she was hardly sleeping. All of this was
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exacerbating her lung problems, dysrhythmias and HF. The Adult Protective Services
department was notified, and she was relocated to clean, decent housing. She was
readmitted a second time, but she reported being much happier and felt safe in her new
home.
African American participants commonly reported being able to count on church
members for help, even if they were not neighbors. While church members may not have
lived close by, they felt they could get emergent assistance from their ministers.
Ministers were usually involved in a weekly face to face meeting with the patients. In
busier churches, the pastor would at least call the member and ask if any assistance was
needed. On weekends, volunteers from the Church would visit or transport members to
church services. Churches also provided a lunch and activities for these participants. In
contrast, Hispanic participants reported having the least amount of social support outside
the family.
Thus, in general, the questions on the Lubben scale regarding ―neighbors‖ elicited
a great deal of explanatory information regarding the level of social contact patients were
having. Even if the scale was not associated with readmission, it may have value as an
assessment of social support and possible need for social services.
Exploratory Analyses of Readmission
Exploratory analyses were also conducted to test for any associations between
readmission status at 30 days or 60 days and BNP levels at admission (Table 7). Among
participants who had a BNP drawn within 24 hours of admission (n = 48), 2 were among
the 12 enrollees excluded from further analysis due to an MMSE < 24 and one failed to
complete the MMSE. The difference in medians was approximately 2475 pg/ml at 30
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days (p = .056) and approximately 2938 pg/ml at 60 days (p = .016). Thus, although the
result at 30 days did not reach statistical significance, it was a substantial difference in
clinical terms. The difference at 60 days was both statistically singnificant and clinically
substantial. All but one of the cases readmitted by 60 days was among those readmitted
within 30 days (Table 8).
Table 8
Admission BNP values (pg/ml) by readmission status at 30 days and 60 days (n = 45)
Percentiles

Ranks

Readmission
Status

n

25th

Median

75th

Mean

Sum

30 days

no

33

326

852

2462

20.74

684.50

yes

12

763

3327

8251

29.21

350.50

no

32

315

845

2249

19.98

639.50

yes

13

767

3782

9247

30.42

395.50

60 days

Mann-Whitney Test
U

Z

p

123.50

-1.91

.056

111.50

-2.42

.016

* For BNP drawn within ± 24 hours of admission
There was no significant association between ejection fraction and readmission
status at 30 days,

2

(df = 5) = 1.73, p = .89, or 60 days,

2

(df = 15) = 5.11, p = .40

(Table 9, data shown for total readmissions at 60 days). There also was no association
between length of stay and readmissions at 30 days, Mann Whitney test, z = -0.35, p =
.72, or total readmissions at 60 days, Mann Whitney test, z = -0.94, p = .35.
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Table 9
Left ventricular ejection fraction by readmission status at 60 days (N = 100)
Not Readmitted (n = 69)

Readmitted (n = 31)

n (%)

n (%)

10 (15)

4 (13)

21-25%

9(13)

8 (26)

26-30%

5 (7)

4(13)

31-35%

16 (23)

3 (10)

36-40%

14 (20)

5 (16)

>40%

15 (22)

7 (22)

Range
<20%
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Chapter 5
Discussion
This prospective descriptive study examined differences in physiological and
psychological variables during a 30 to 60 day period following an index hospitalization
for HF. It was hypothesized that patients who were readmitted for HF within 30 or 60
days of discharge from the index hospitalization would have more severe depressive
symptoms (higher GDS-15 scores) or greater social isolation (lower Lubben scale scores)
during the index hospitalization than patients who were not subsequently readmitted for
HF. No statistically significant or clinically meaningful association was found between
readmission and either depressive symptoms or social isolation.
In exploratory analyses, a significantly higher admission BNP for the index
hospitalization was found in those who had been readmitted at least once within 60 days,
of discharge compared to those with no readmissions. The difference was large enough to
be clinically meaningful in addition to being statistically significant. For readmissions at
30 days, the difference in admission BNP was large enough to be clinically meaningful,
although it fell short of the threshold for statistical significance. No statistically
significant association was found between readmission at 30 or 60 days ejection fraction
or between readmission and length of stay.
Statistical Assumptions
Prior to the study, it was estimated that 120 subjects would be needed for
adequate ( > 80%) statistical power to detect a potentially meaningful difference in GDS
scores, based on an expectation of 20% readmission rate (24 readmissions). Due to postenrollment determination of ineligibility (n=13), approximately 90% (107/120) remained
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eligible of whom 94% (101/107) completed the GDS. However, the actual readmission
rates were higher than the 20% on which the sample size estimate was based; 27%
(27/101) within 30 days and 31% (34/101) at least once by 60 days following discharge
from index hospitalization. In addition, it was apparent that very few participants had a
GDS score consistent with increased risk for depression. Therefore a decision was
reached, in consultation with the dissertation chair, to discontinue enrollment. Due to the
low reliability of the GDS in this sample, no attempt was made to estimate observed
power, so the actual statistical power of the study is unknown. However, there was a
moderate to large, statistically significant difference in admission BNP for the index
hospitalization between those who were readmitted at least once within 60 days and those
who were not readmitted. Therefore there was adequate statistical power to detect a
clearly meaningful difference in admission BNP values.
With respect to the unacceptability low reliability of the GDS-15 in this study,
Kieffer and Reese (2002) reviewed studies in which reliabilities for the GDS were either
reported or could be calculated from the published data. Despite a mean reliability of .85,
they found published reports of reliability coefficients as low as 0.41 and calculated some
reliabilities to have been as low as .11.
Theoretical Assumptions
For the purposes of this study, social isolation was viewed primarily as an
antecedent situational factor and depression was viewed as primarily a symptom. The
TOUS (Lenz et al., 1995, 1997) portrays dimensions of intensity, quality, duration, and
distress of individual symptoms or symptom clusters. When symptoms cluster, which is
common in heart failure, the symptoms may have synergistic effects that exceed the sum
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of separate effects. Because symptoms other than depression were not included, any
potential synergy between depressive and other symptoms (e.g., fatigue, dyspnea) could
not be assessed.
Physiological factors. With respect to BNP, Wu, Harrison and Maisel (2004)
studied 344 cases in which BNP was ordered on admission. They found that BNP may
have enabled more HF patients to be treated properly through proper identification, but
BNP served only to reduce the number of incorrectly diagnosed readmissions. Ancheta et
al. (2009) also found that clinician’s awareness of BNP levels was not associated with
improvements in outcomes including quality of life and length of stay.
Bettencourt, et al. (2004) studied 182 patients admitted for HF and followed for
six months. They found that variables associated with an increase for readmission or
death were heart rate, length of stay, volume overload, no ACE-inhibitor prescribed at
discharge and changes in BNP levels between admission and discharge (i.e., not just BNP
at admission). The median admission BNP level was 6778 pg/ml and the median level at
discharge was 4137 pg/ml. The variation in BNP was the strongest predictor of an
adverse outcome. Similarly, Lainchbury et al. (2009) studied BNP guided therapy in 384
patients. They found that pharmacotherapy guided by BNP peptides improved mortality
at one year.
In the present study, higher BNP levels within 24 hours of the index admission
were associated with readmission. The median difference between those readmitted and
those not readmitted was approximately 2400pg/ml at 30 days and 2900 pg/ml at 60 days,
both of which would be considered clinically meaningful. Thus, it is possible that higher
BNP values at admission may be associated with an increase in risk for readmissions.
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However, the analysis was limited because a majority of participants (those with an
already confirmed diagnosis of heart failure) did not have BNP levels ordered within 24
hours of admission because a result would not have altered clinical decision making.
In the Worcester Heart Failure study (Saczynski, Darling, Spencer, Lessard, Gorre
& Goldberg (2009) 4,534 participants hospitalized for possible HF were recruited, of
whom only 37% had documented ejection fractions. In this sub-group of participants,
patients were younger, had a lower body mass index, and were less likely to have a
medical history of diabetes, cancer or renal disease. As in the present study, EF alone
was not found to be a predictor of readmission. The thirty day crude mortality rate in
patients with documented EF showed that mortality rates increased with age from 5.5%
in patients < 65years of age to 17.6% in those aged 85 or older.
With respect to ejection fraction, Torre-Amione et al., (2009) studied acute heart
failure and symptoms of worsening heart failure. In this randomized hemodynamic study,
they found that patients admitted with acute HF (AHF) were older, about half were
women, half had preserved left ventricular ejection fraction and 20% had new onset HF
as compared with younger age and significantly male predominance and chronic HF
cohorts. They concluded that the pathogenesis and course of AHF could be determined
by factors different from those affecting the course and outcome of chronic HF.
McMurray and Pfeffer (2004) also observed that impaired left ventricular ejection
fraction correlated with adverse outcome in patients with chronic HF, but did not
correlate with worse outcome in patients with AHF. Torre-Amione et al. (2009) believe
that AHF may have different end points, for example prevention of a readmission during
an acute HF episode is not as important an outcome as clinical stabilization and
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improvement in symptoms. No studies demonstrating a significant association between
length of stay and readmission were found.
Situational factors. This study also found that social isolation was not a
predictor for readmission. From a theoretical perspective, the TOUS does not specify the
strength or direction of any associations among situational, physiological, and
psychological antecedent factors. However, it is reasonable to assume that, in general,
worse antecedent or baseline status would be associated with worse performance or
outcomes.
Sorkin et al. (2002) studied 180 elderly patients and found that patients who
perceived loneliness had longer lengths of stay than persons who did not report perceived
loneliness, but this was not specific to patients with heart conditions, and they did not
investigate readmissions. Sorkin and associates also examined the possible mediating
mechanisms by which loneliness might influence the probability of having a heart
condition: the first analysis examined the possibility that physiological factors (serum
cholesterol, body mass index) might mediate the association between loneliness and the
probability of having a heart condition. Triglyceride levels and BMI did not mediate the
relation between loneliness and having a heart condition. Sorkin et al. also examined
affect states: depression did not serve as a mediator (Ms = 9.26 vs 9.17).
Psychological factors. With respect to depression, Redwine et al. (2007)
followed 18 men with HF over a two year period. They found that certain physiological
factors previously thought to be related (e.g. body mass index, level of BNP, and EF)
were not correlated to depression scores. Patients who were re-hospitalized over a two
year period had higher depression scores at baseline. Redwine and colleagues also found
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that there was a negative linear relationship between the number of depressive symptoms
and the ratio of Th1/Th2 leukocytes at baseline among the HF patients (Th1 cells
promote cellular immunity by rapidly producing a range of cytokines; Th2 cells produce
cytokines such as IL-4 and IL-10). Patients who were re-hospitalized and or died due to
cardiovascular events over a two year period had higher depression scores as well as
reduced Th1/Th2 ratios at baseline. In addition, HF patients with high depression scores
had lower cellular immunity, as evidenced by a shift in interferon gamma/interleukin-10
ratios in Th2 cells. These findings by Redwine suggest that an association between
depression and compromised immune status may contribute to the relationship between
depression and cardiac morbidity and, mortality over a period of several years.
In the present, study the total rate of depressive symptomology was 8.9%, with
the depressed sample consisting of 4 men and 5 women. Assuming a reliable measure
had been used, it may have been that a much higher severity or duration of depression
(greater variability in scores) would have been needed to detect any association with
readmission for this population. Alternatively, the readmission interval may have been
too short to detect a meaningful relationship.
The TOUS examines symptoms based on intensity/severity, duration/timing,
distress and quality. In this study, a score of 5 categorized a person as potentially
depressed. Kieffer and Reese (2002) point out that reliability is a property of scores on an
instrument (i.e., an interaction between the instrument and the population and setting in
which it is used) rather than a property of the instrument independent of the context in
which it is used. In this study the reliability of scores may have been adversely affected
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by sampling biases that were an artifact of requiring access to patients through their
physicians.
Although possible effects of gender are not explicitly localized in the TOUS
model, no relationship was found between gender and readmission in the present study.
This is consistent with findings of Lee, Capra, Jensvold, Gurwitz and Go (2004) over a
twelve month period. D‘Ath and associates (1994) studied 194 elders at a single point in
time and found the mean GDS-15 scores to be 3.7, but with a range of 0-15 points and
approximately one third in the depressed range (34% overall, 35% of men and 33% of
women) They found no statistically significant relationships between GDS score and
either age group (65-74 years vs. 75 or older) or gender.
In the present study no clinically or statistically significant differences in
depression scores were found for race and ethnicity. Again, the ability to detect any such
difference was adversely affected by the low score variability and unacceptably low
reliability of the GDS-15 in the present sample. However, some similarities to previously
reported studies were found.
Previous research has demonstrated that Hispanic females are at greater risk of
depression due to poverty and lack of economic resources (Chiriboga, Black, Aranda, &
Markides, 2002). Unmarried Hispanic elder females are 2.5 times more likely to be
depressed than their married counter parts (Falcón & Tucker, 2000). While this study, did
not ask questions related to family structure, it is worth mention that Hispanic caregivers
of adults with dementia have been found to be more likely than Black or White
caregivers to have GDS-15 scores of 6 or higher (Covinsky, et al., 2003).
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In this study, Hispanics tended to the word nervios (―nerves‖) to describe
symptoms of depression, which has been reported in Puerto Ricans (Guarnaccia, LewisFernández, & Marano, 2003) and Mexican-Americans (Newton, 1978, as cited in
Guarnaccia et al., 2003). Guarnaccia et al. assert that such usage is also common in other
Latin American cultural groups, although probably with cross-cultural variations in what
is meant. Stigma may also influence how elders and minorities self report depression
(Interian, Martinez, Guarnaccia, Vega, & Escobar, 2007).
In this study, no African American participants reported feeling depressed. Other
studies have reported that African Americans may conceptualize depression differently
than Whites (Blazer et al., 1998; Gallo et al., 1998; Kirmayer, 2001), and that the African
American population may also attach stigma to mental illness, thus also affecting
responses in self rating instruments (Mills, 2004).
Limitations
Limitations of this study include sample size and potential selection bias. The
sample size estimate was based on analysis of readmission statistics in the participating
hospitals, based on all HF admissions, not just patients 65 years of age or older, let alone
those willing to participate in an observational research study. However, the number and
percentage of readmissions in the sample (n= 31, 31%) was somewhat greater the prior
estimate of a 20% readmission rate. Thus, although the statistical power of the study was
almost certainly lower than 80%, there were a sufficient number of readmissions for
meaningful analysis of other variables.
Convenience sampling and having to ask provider permission were limiting
factors. Providers may have been hesitant to allow the researcher to speak with depressed
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patients or sicker patients. Also, self selection bias among people who are depressed may
have played a role. For example, among the patients who were actually approached for
recruitment, none who stated they had depression agreed to participate in the study. It is
reasonable to assume that factors affecting willingness to volunteer introduce a self
selection bias especially since this was an observational study with no direct benefit to
participants.
Almeida, Kashdan, Nunes et al (2008) reported that more anxious, socially
avoidant and depressed people are less likely to volunteer for participation in research
studies. All of these factors potentially affect the representativeness of the study sample
and impact both internal and external validity. Therefore, the extent to which the study
results can be generalized beyond the sample may be quite limited. While these
participants may not represent the population of all patients hospitalized for HF in terms
of psychosocial characteristics, they were reasonably representative of the HF population
served by the hospital system in terms of demographic and clinical variables, for example
age, sex, race, ethnicity, BNP at admission, ejection fraction, length of stay, and rate of
readmissions.
Another limiting factor was the amount of time the participants were followed.
Readmission was assessed at 30 and 60 days post discharge. As it turned out, nearly all of
those readmitted within 60 days of discharge had also been readmitted within 30 days
(27/31; 87%)., and, in the BNP analysis, a change in readmission status of a single case
accounted for the result changing from not statistically significant to statistically
significant. No outside readmissions were encountered, however only 15% of
respondents were successfully reached by telephone. This potentially could have resulted
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in misclassification and undercounting of readmissions. Thus, the actual readmission
rates may have been higher. While readmissions were all related to heart failure, it may
well have been the case that a longer follow up interval (e.g. 6 months, a year) would
have been better.
Although there have been many studies of readmission in heart failure (Krumholz
et al, 1997; Gooding & Jette, 1985, Krumholz et al., 2000; and Harjai, Thompson, Turgut
& Shah, 2001) there is no consensus across studies as to what an optimal follow-up
interval should be. In addition, some studies have recruited HF patients only after a
recent hospitalization instead of during an acute hospital stay (Fulop et al., 2003). Some
have used a combined endpoint of death or any hospitalization as opposed to readmission
alone following a specific hospitalization (Redwine et al., 2007; Vaccarino, et al., 2007)
and others have been based entirely on existing administrative data (Anderson,
Freedland, Clouse, & Lustman, 2001). Such issues also impact internal and external
validity of previous studies of readmission, and differences in design, endpoints, and
timeframes for readmission complicate comparing results across studies.
In summary, the study was unable to substantiate that depression or social
isolation affects readmissions over a 30 to 60 day interval following discharge from an
index hospitalization for HF. The results do not rule out a possible role for screening for
depression and social isolation during an admission for HF. Clinical guidelines for
cardiovascular care recommend that screening for depression should be considered
(Lichtman et al., 2008) and no harm related to screening has been identified (Thombs, de
Jonge, Coyne, Whooley et al, 2008). More research on the impact of depression
screening is needed and the impact various depression tools may have: different
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instruments measure different symptoms, and a self reported instrument varies from an
interview or an observer rated instrument for major and minor depression. It is yet to be
determined which instrument may be more beneficial among HF patients.
The results of this study also do not rule out a possible need for a longer followup interval if readmission is an outcome of interest. It may well be that depression and
social isolation do not manifest themselves until several years after a person has had HF,
and may require a longer interval than 60 days for an impact on rehospitalization to be
detected. Jiang and associates (2001) found that readmissions were high for major
depression after 3 months of a previous admission (52%) and after one year the
readmission rate was 80%. Future research may also be needed to specify the follow up
period needed before manifestation of depression is detectable.
There is also the possibility that several psychosocial variables may need to be
measured in addition to depression, for example anxiety and loneliness. The complexity
of psychological and situational factors may interact with symptoms leading older adults
to judge their health unfavorably and to perceive deficits in their social networks. Future
research is recommended to examine which variables may mediate the relationship
between social isolation, loneliness and a readmission or a death.
Future research is also recommended at examining physiological symptoms and
their interactions and mediating effects among each other, for example, dyspnea and
fatigue may also be interacting with each other affecting rates of perceived depression
and affecting perceived level of social isolation. It is important to identify which
mechanisms account for the poor outcomes: a larger, more representative sample, with a
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broader range of depressive scores might show strong evidence that depression and
physiological factors mediate each other.
Future research should also be directed at examining the role BNP levels have
with relation to readmissions. Serial BNP levels might prove useful in assessing risk for
readmissions among HF patients (Wilson Tang et al., 2007) and might even be of value
in identifying patients who need more intensive surveillance and treatment to prevent
readmission. The concept of BNP guided management of HF is still under investigation.
In closing, it should be noted that the purpose of any screening measurement is to
identify individuals for whom more comprehensive and definitive assessment is
warranted. Diagnostic and treatment should never rely solely on information provided by
a screen. Depression and social isolation may be important enough on their own, even if
they do not predict readmission, to be worth screening for during an acute hospital
admission. Continued efforts are needed to decrease burden of hospitalization and other
adverse outcomes in these high risk patients.
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Appendix A
Geriatric Depression Rating Scale (English Version)
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GERIATRIC DEPRESSION RATING SCALE
Brink et al., 1982; Yesavage et al., 1983 - SHORT version - Sheik et al., 1986
Choose the best answer for how you have felt over the past week:
Yes / No
[

] [

] 1. Are you basically satisfied with your life?

[

] [

] 2. Have you dropped many of your activities and interests?

[

] [

] 3. Do you feel that your life is empty?

[

] [

] 4. Do you often get bored?

[

] [

] 5. Are you in good spirits most of the time?

[

] [

] 6. Are you afraid that something bad is going to happen to you?

[

] [

] 7. Do you feel happy most of the time?

[

] [

] 8. Do you often feel helpless?

[
] [
things?

] 9. Do you prefer to stay at home, rather than going out and doing new

[

] [

] 10. Do you feel you have more problems with memory than most?

[

] [

] 11. Do you think it is wonderful to be alive now

[

] [

] 12. Do you feel pretty worthless the way you are now

[

] [

] 13. Do you feel full of energy?

[

] [

] 14. Do you feel that your situation is hopeless?

[

] [

] 15. Do you think that most people are better off than you are?

TOTAL GDS:
(GDS maximum score = 15)
0 - 4 normal, depending on age, education, complaints
5 - 8 mild
8 - 11 moderate
12 - 15 severe
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Appendix B
Geriatric Depression Rating Scale (Spanish Version)

94

GDS-15 adapted from Fernández-San Martín et al., (2002)
1. ¿En general se siente satisfecho con su vida?
2. ¿Ha abandonado muchas de sus actividades e intereses?
3. ¿Siente que su vida está vacía?
4. ¿Se aburre con frecuencia?
5. ¿Esta de buen humor la mayor parte del tiempo?
6. ¿Tiene miedo que le suceda algo malo?
7. ¿Se siente feliz la mayor parte del tiempo?
8. ¿Siente con frecuencia que nada o nadie le puede ayudar?
9. ¿Prefiere quedarse en case en vez de salir y hacer cosas nuevas?
10. ¿Siente que tiene más problemas de memoria que los demás?
11. ¿Piensa que es maravilloso estar vivo?
12. ¿Se siente inútil tal y como esta ahora?
13. ¿Se siente lleno de energía?
14 ¿Cree que su situación no tiene salida?
15. ¿Cree que la mayoría de la gente está en mejor situación que usted?
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Appendix C
Lubben Social Isolation Questionnaire (English Version)
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LUBBEN SOCIAL NETWORK SCALE – 18LSNS-18
FAMILY Considering the people to whom you are related either by birth or marriage…
1. How many relatives do you see or hear from at least once a month?
0 = none
1 = one
2 = two
3 = three or four
eight
5 = nine or more

4 = five thru

2. How often do you see or hear from relative with whom you have the most contact?
0 = never
always

1 = seldom

2 = sometimes 3 = often

4 = very often 5 =

3. How many relatives do you feel at ease with that you can talk about private matters?
0 = none
eight

1 = one
2 = two
5 = nine or more

3 = three or four

4 = five thru

4. How many relatives do you feel close to such that you could call on them for help?
0 = none
1 = one
2 = two
3 = three or four
4 = five thru
eight
5 = nine or more
5. When one of your relatives has an important decision to make, how often do they talk
to you about it?
0 = never
1 = seldom
2 = sometimes 3 = often
4 = very often 5 =
always
6. How often is one of your relatives available for you to talk to when you have an
important decision to make?
0 = never
1 = seldom
2 = sometimes 3 = often
4 = very often 5 =
always
NEIGHBORS: Considering those people who live in your neighborhood….
7. How many of your neighbors do you see or hear from at least once a month?
0 = none
1 = one
2 = two
3 = three or four
4 = five thru
eight
5 = nine or more
8. How often do you see or hear from the neighbor with whom you have the most
contact?
0 = never
1 = seldom
2 = sometimes 3 = often
4 = very often 5 =
always
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9. How many neighbors do you feel at ease with that you can talk about private matters?
0 = none
1 = one
2 = two
3 = three or four
4 = five thru
eight
5 = nine or more
10. How many neighbors do you feel close to such that you could call on them for help?
0 = none
1 = one 2 = two 3 = three or four 4 = five thru eight
5 = nine or
more
11. When one of your neighbors has an important decision to make, how often do they
talk to you about it?
0 = never
always

1 = seldom

2 = sometimes 3 = often

4 = very often 5 =

12. How often is one of your neighbors available for you to talk to when you have an
important decision to make?
0 = never
1 = seldom
2 = sometimes 3 = often
4 = very often 5 =
always
FRIENDSHIPS: Considering your friends who do not live in your neighborhood….
13. How many of your friends do you see or hear from at least once a month?
0 = none
1 = one
2 = two
3 = three or four
4 = five thru
eight
5 = nine or more
14. How often do you see or hear from the friend with whom you have the most contact?
0 = never
1 = seldom
2 = sometimes 3 = often
4 = very often 5 =
always
15. How many friends do you feel at ease with that you can talk about private matters?
0 = none
1 = one
2 = two
3 = three or four
4 = five thru
eight
5 = nine or more
16. How many friends do you feel close to such that you could call on them for help?
0 = none
1 = one 2 = two 3 = three or four 4 = five thru eight
5 = nine or
more
17. When one of your friends has an important decision to make, how often do they talk
to you about it?
0 = never
always

1 = seldom

2 = sometimes 3 = often
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4 = very often 5 =

18. How often is one of your friends available for you to talk to when you have an
important decision to make?
0 = never
1 = seldom
2 = sometimes 3 = often
4 = very often 5 =
always

LSNS-R total score is an equally weighted sum of these items. Scores range from 0 to 90.
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Appendix D
Lubben Social Isolation Questionnaire (Spanish Version)
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LSNS-18

FAMILIARES Incluye las personas con las que usted está emparentado, ya sea por
nacimiento o por matrimonio …
1. ¿Con cuántos parientes se reúne o habla por lo menos una vez al mes?
0 = ninguno 1 = uno
2 = dos
3 = tres y cuatro
4 = cinco a ocho
5 = nueve o más
2. ¿Con qué frecuencia se reúne o habla con el pariente con el que tiene mayor contacto?
0 = nunca 1 = rara vez
siempre

2 = a veces

3 = a menudo 4 = muy a menudo

5=

3. ¿Con cuántos parientes se siente usted en confianza para tratar asuntos privados?
0 = ninguno 1 = uno 2 = dos
5 = nueve o más

3 = tres y cuatro

4 = cinco a ocho

4. ¿Con cuántos parientes se siente usted en confianza como para pedirles ayuda?
0 = ninguno 1 = uno 2 = dos
3 = tres y cuatro
4 = cinco a ocho
5 = nueve o más
5. Cuando alguno de sus parientes debe tomar una decisión importante, ¿qué tan a
menudo le hablan sobre ello?
0 = nunca 1 = rara vez
2 = a veces
3 = a menudo 4 = muy a menudo
5=
siempre
6. ¿Con qué frecuencia está disponible alguno de sus parientes para hablar cuando usted
tiene una decisión importante que tomar?
0 = nunca 1 = rara vez
2 = a veces
3 = a menudo 4 = muy a menudo
5=
siempre
VECINOS: Incluye aquellas personas que viven en su vecindad….
7. ¿ Con cuántos vecinos se reúne o habla por lo menos una vez al mes?
0 = ninguno 1 = uno
2 = dos
3 = tres y cuatro
4 = cinco a ocho
5 = nueve o más
8. ¿ Con qué frecuencia se reúne o habla con el vecino con quien mantiene mayor
contacto?
0 = nunca 1 = rara vez
2 = a veces
3 = a menudo 4 = muy a menudo
5=
siempre
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9. ¿ Con cuántos vecinos se siente usted en confianza para tratar asuntos privados?
0 = ninguno 1 = uno 2 = dos
3 = tres y cuatro
4 = cinco a ocho
5 = nueve o más
10. ¿ Con cuantos vecinos se siente usted en confianza como para pedirles ayuda?
0 = ninguno 1 = uno
2 = dos
3 = tres y cuatro 4 = cinco a ocho
5 = nueve o más
11. Cuando alguno de sus vecinos debe tomar una decisión importante, ¿qué tan a
menudo le hablan sobre ello?
0 = nunca 1 = rara vez
siempre

2 = a veces

3 = a menudo 4 = muy a menudo

5=

12. ¿ Con qué frecuencia está disponible alguno de sus vecinos para hablar cuando usted
tiene una decisión importante que tomar?
0 = nunca 1 = rara vez
2 = a veces
3 = a menudo 4 = muy a menudo
5=
siempre
AMISTADES: Incluye sus amistades que no viven en su misma vecindad….
13. ¿ Con cuántos amigos se reúne o habla por lo menos una vez al mes?
0 = ninguno 1 = uno 2 = dos
3 = tres y cuatro
4 = cinco a ocho
5 = nueve o más
14. ¿ Con qué frecuencia se reúne o habla con el amigo con quien mantiene mayor
contacto?
0 = nunca 1 = rara vez 2 = a veces
3 = a menudo 4 = muy a menudo
5=
siempre
15. ¿Con cuántos amigos se siente usted en confianza para tratar asuntos privados?
0 = ninguno 1 = uno
2 = dos
3 = tres y cuatro
4 = cinco a ocho
5 = nueve o más
16. ¿ Con cuantos amigos se siente usted en confianza como para pedirles ayuda?
0 = ninguno 1 = uno 2 = dos 3 = tres y cuatro 4 = cinco a ocho 5 = nueve o más
17. Cuando alguno de sus amigos debe tomar una decisión importante, ¿qué tan a
menudo le hablan sobre ello?
0 = nunca 1 = rara vez 2 = a veces
siempre

3 = a menudo 4 = muy a menudo
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5=

18. ¿ Con qué frecuencia está disponible alguno de sus amigos para hablar cuando usted
tiene una decisión importante que tomar?
0 = nunca 1 = rara vez
2 = a veces
3 = a menudo 4 = muy a menudo
5=
siempre

LSNS-R el resultado total es una suma ponderada equitativamente entre estas partidas. La
escala de los resultados es 0 al 90.
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Consent to Participate in a Research Study (English)
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Appendix F
Consent to Participate in a Research Study (Spanish)
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CONSENTIMIENTO PARA PARTICIPAR EN UNA INVESTIGACION
Factores de riesgo no cardíacos y readmisión por insuficiencia cardíaca
CPHS-HSC-GEN-08-0496

Se le invita a un estudio de investigación conducido por Irma Samaniego, RN, MSN,
PhD candidata y Mark Parshall, PhD, RN, Profesor Asociado de la Escuela de
Enfermería de la Universidad de New Mexico, Albuquerque, NM.
Su decisión en el presente estudio es enteramente voluntaria y no afectara su tratamiento
o servicios en el hospital Memorial Hermann o el tratamiento de su medico.
Usted no tiene que contestar preguntas. Le agradecemos leer la información que aparece
a continuación y formular sus preguntas sobre cualquier aspecto que no comprenda, antes
de hacer una decisión
Algunos de los otros requisitos para ser elegible al estudio incluyen tener por lo menos 65
años de edad y vivir en su casa, hablar y entender ya sea inglés o español, y ser capaz de
dar un consentimiento informado. Habrá unos 120 hombres y mujeres. Si usted está de
acuerdo, será entrevistado a su conveniencia, durante su estadía en el hospital como
paciente. La entrevista incluirá varios cuestionarios y durará aproximadamente 15-20
minutos. Además, obtendremos cierta información de su expediente médico. No existe
tratamiento experimental en este estudio.
PROPOSITO DEL ESTUDIO
El propósito del estudio es aprender más sobre los factores sicológicos y apoyo social en
pacientes hospitalizados por insuficiencia cardiaca. Dicho estudio es importante para la
profesión de enfermería debido a que sus resultados pueden ayudar a encontrar maneras
más eficaces de atender a las personas con insuficiencia cardíaca.

PROCEDIMIENTOS
Si usted accede, se le pedirá lo siguiente:
Responder varias preguntas, como por ejemplo, ¿qué día es?, ¿qué hora es? Estas
preguntas están diseñadas con el fin de ayudar a decidir su nivel de entendimiento
(función cognitiva).
Luego se le pedirá completar dos cuestionarios, uno de los cuales tiene preguntas
que pueden responderse con un si o un no, mientras que el otro tiene preguntas
que requieren como respuesta números o clasificaciones por frecuencia.
Ejemplos de preguntas si/no:
“¿Está usted básicamente satisfecho con su vida?” y
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“¿Piensa usted que la mayoría de las personas están en mejor
situación que usted?”
Ejemplos de preguntas que requieren números o clasificaciones:
“¿Cuántos de sus amigos le visitan o llaman por lo menos una vez
al mes?” y
“¿Con qué frecuencia puede usted conversar con alguno de sus
parientes o familiares cuando tiene que tomar una decisión
importante?”
Se le preguntará su edad, sexo, raza y grupo étnico, estado civil y el nivel de
educación (estudios cursados).
Se le pedirá permiso para revisar su expediente médico.
La información a ser obtenida incluye el tipo y la severidad de la
insuficiencia cardíaca que usted padece, los resultados de sus pruebas
diagnósticas y de laboratorio, medicamentos, y el número de días que
lleva en el hospital.
Al mes de su alta del hospital, el investigador comprobará también los
expedientes administrativos para determinar si usted fue admitido más de
una vez por insuficiencia cardiaca ese mes. Además, el investigador le
contactará por vía telefónica o por correo (el que usted prefiera) para
determinar si ha sido admitido a cualquier otro hospital en un lapso de 30
días contados a partir de su fecha de alta de este hospital.
No existe seguimiento alguno distinto al estudio en cuestión.

POSIBLES BENEFICIOS PARA LOS PARTICIPANTES Y/O LA SOCIEDAD
Este estudio no se conduce con la finalidad de mejorar su condición o salud. Usted está
en su derecho a rehusarse de participar en el estudio.
Uno de los beneficios de su participación incluye que si se llega a determinar que usted
posee síntomas particulares que pudiesen sugerir depresión o aislamiento, su médico sería
notificado.
Su participación en el estudio puede ayudar a médicos y enfermeras a encontrar maneras
más eficaces de atender a las personas con insuficiencia cardíaca. Estos cuestionarios
pueden ayudar identificar personas que puedan necesitar adicionales servicios.

POSIBLES RIESGOS E INCONVENIENTES
Puede experimentar un riesgo mínimo durante el presente estudio. Como resultado de
esta investigación, podría identificar sentimientos o asuntos que le han venido
perturbando. Si alguna de las preguntas le llegase a incomodar por alguna razón, no está
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en obligación de responderla. Podría asimismo cansarse durante su entrevista. Si esto
ocurre, el investigador hará una pausa y le permitirá descansar. Si no desea continuar con
el estudio, tan solo dígale al investigador, quien le agradecerá haber donado su tiempo y
finalizará su participación en el estudio.
CASOS DE LESIONES FISICAS
En el caso de una lesión física y/o mental resultante de la participación en este proyecto
de investigación, no proveerá seguro alguno médico, hospitalización u otro tipo de
cobertura a los participantes de este estudio de investigación. Todas las facilidades para
obtener tratamiento do emergencia y servicios profesionales estarán a su disposición, asi
como a la comunidad. Usted debe de reportar lesiones físicas a Irma Samaniego (713)
704-8006 y al Comité para la Protección de los Sujetos Humanos (CPSH) (713) 5007943. Usted mantiene sus derechos legales firmando este consentimiento.
COSTOS Y COMPENSACION
Ninguno.
CONFIDENCIALIDAD
Cualquier información obtenida en relación a este estudio y que puede ser identificada
con su persona, permanecerá confidencial y será divulgada solamente con su permiso o
según exige la ley. La confidencialidad se mantendrá asignando a los participantes un
número de identificación anónimo para el estudio.
Existe una forma de autorización que se le solicitara firmar. Esta forma contiene detalles
sobre come se divulga información personal.
RETIRO
Usted puede escoger si participa o no en este estudio. Si se ofrece a estar en el estudio,
puede retirarse del mismo cualquier momento sin consecuencias de ningún tipo o pérdida
de beneficios a los cuales tiene derecho. También puede rehusarse a contestar cualquier
pregunta que no desee contestar. No será penalizado si se retira del estudio y no perderá
beneficio alguno al cual tiene derecho.
El investigador puede asimismo retirarle del estudio si surgen circunstancias que lo
ameritan, tales como un cambio en su diagnóstico o en su pronóstico.
PREGUNTAS
En caso de tener alguna pregunta o inquietud acerca de la presente investigación, le
agradecemos contactar a:
Investigador Principal- Irma Samaniego, RN, MSN, PhDc al 713-704-8006;
email: irma.samaniego@memorialhermann.org
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Patrocinador de la Facultad: Mark Parshall, RN, PhD al 505-272-4540;
email: mparshall@salud.unm.edu
Firma
Firme si ha entendido la información que se le ha dado. Este seguro de que sus preguntas
han sido respondidas a su satisfacción, y que usted este de acuerdo con este estudio. Si
tiene preguntas sobre sus derechos llame al Comité para la Protección de los Sujetos
Humanos (CPSH) (713) 500-7943. Si decide tomar parte en este estudio, le daremos una
copia de este formulario.

Nombre del Participante

Firma del Participante

Fecha

Nombre del Investigador

Firma del Investigador

Fecha

_____________________________________________________________
Este estudio (HSC-GEN-08-0496) ha sido revisado por el Comité para la Protección de
los Sujetos Humanos (CPSH) del University of Texas Health Science Center, Houston.
Si tiene cualquier pregunta sobre sus derechos en el presente estudio, o para reportar
lesiones relacionadas con este estudio llame al Comité para la Protección de los Sujetos
Humanos (The Committee for the Protection of Human Subjects) al teléfono (713) 5007943
Gracias
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Appendix G
Authorization for the Use and Disclosure of Protected Health Information
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